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TITLE OF THE ABSTRACT: Study to assess the requirement of a routine upper GI 
contrast study post-operatively in patients undergoing an oesophageal anastomosis – a 
randomized control trial. 
DEPARTMENT                       : General Surgery, Unit III, CMC, Vellore 
NAME OF THE CANDIDATE  :  Dr. Niveditha Shama Viswanathan 
DEGREE AND SUBJECT           : M.S. General Surgery 
NAME OF THE GUIDE        : Dr. Inian Samarasam 
 
OBJECTIVES: 
1. To compare the delay in starting oral feeds, liquids and solids, duration of post-
operative hospital stay and to compare readmission and re-surgery rates.  
2. To evaluate the overall morbidity and 30 day mortality in the two groups. 
 
METHODS:  
 A prospective randomized control study was carried out to assess the need of a 
routine upper GI contrast study after an oesophageal anastomosis. All patients 
undergoing an oesophageal anastomosis were randomized into 2 groups.  
The patients from Group A underwent a routine upper GI contrast study between post-
operative day 5 to day 7. None of the patients from Group B underwent a routine 
upper GI contrast study. However, they underwent an appropriate radiological 
assessment post operatively, if a leak was suspected. The outcomes were assessed as 
per objectives.  
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RESULTS: 
Among the 40 patients recruited, it was found that there were no significant 
differences in length of hospital stay and the time to starting liquid feeds orally 
between the 2 groups. However, there is a probable statistically significant delay of 1 
day in starting solid feeds. There was no added morbidity in the non-contrast study 
group. Thus, it can be concluded that the practice of doing a routine upper GI contrast 
study after an oesophageal anastomosis may not be necessary unless there are strong 
indicators to perform it. Instead, monitoring the patient’s clinical parameters to look 
out for clinical evidence of a leak, followed by performance of an appropriate 
investigation to confirm or rule out a leak may be a more appropriate practice.  
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2.0 INTRODUCTION: 
In patients undergoing an oesophageal anastomosis, post-operatively, a routine upper 
GI fluoroscopic imaging with thin Barium Sulfate/ Gastrografin has been employed to 
assess the integrity of the anastomosis, prior to initiation of feeding orally. However, 
this modality is plagued by a low sensitivity, and its routine use has been questioned 
in the last decade. The aim of this study was to assess outcomes between a group who 
had the routine upper GI contrast study and a group where a routine contrast was not 
performed. . 
 
2.1 BACKGROUND DATA: 
A number of retrospective studies have been carried out to assess the need of doing a 
routine upper GI contrast study on the 7
th
 postoperative day following an oesophageal 
anastomosis. In most of the studies published, only 70% of anastomotic leaks were 
detected within the first five days.(1) Moreover, even if the upper GI contrast study 
done on day 7 was normal, this did not preclude a delayed leak occurring as late as 
one month after surgery (maximum period). This resulted in delayed leaks being 
missed out and a consequent delay in intervention. 
 
2.2 CURRENT LITERATURE: 
Anastomosis of the oesophagus to the stomach or jejunum or colon is done widely in 
many surgical conditions like oesophageal cancer, gastric cancer, after resection of 
oesophageal or gastric strictures (due to corrosives) etc. Prior to starting oral feeds, 
post operatively, the routine practice has been to carry out an upper GI contrast study 
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as a screening procedure for anastomotic leaks. This practice is still followed by many 
centers, including ours. However, studies have suggested a poor sensitivity and high 
false negative error rate of this test. In a series with clinical anastomotic leak rate of 
9%, it was found that the test was insufficient to be worthwhile as a screening 
procedure(2)(3)
. 
A study series further went on to show that 56.3% of anastomotic leaks were 
diagnosed without contrast studies. Contrast studies changed clinical management 
correctly in only 2 of 132 patients, while failing to diagnose 4 of 7 possible leaks. 
Hence the indication for a routine upper GI contrast study was questioned.(4) 
Further studies have proven that, post operatively upper GI contrast studies can be 
selectively done in patients with clinical suspicion and clinical signs of anastomotic 
leakage including sepsis, fever > or = 39.0 degrees C and leukocytosis > or = 20 x 
10
9
/ml.
 
(5)(6)
 
Currently, there is proof to suggest that a routine upper GI contrast study 
has minimal impact in the postoperative management of patients undergoing 
oesophageal anastomosis.(7)  
 
2.3 INDICATIONS FOR OESOPHAGEAL RESECTION AND ANASTOMOSIS: 
Oesophageal surgery has evolved a long way since the early 1800s. The most common 
indications of oesophageal resection can be divided into benign and malignant causes. 
The common benign tumors are GISTs, leiomyomas, lipomas etc. The malignancies 
include adenocarcinomas, squamous cell carcinomas, etc. Other indications include 
benign strictures secondary to corrosive ingestion or certain drugs. In malignancies of 
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the oesophagus, surgery still remains the treatment of choice, backed by neo-adjuvant 
and adjuvant therapies.  
 
2.4 OESOPHAGEAL RESECTION TECHNIQUES: 
The oesophageal resections are performed in differing approaches and techniques 
depending on the type and the location of tumors. They include: 
1. Two phase Ivor Lewis’ Operation: Here the abdominal and thoracic cavities are 
opened together to excise the tumor and create a gastric tube to bridge the defect. This 
places the anastomosis in the thoracic cavity, thereby conferring an added risk of fatal 
mediastinitis in case of an anastomotic leak. This is preferred in middle and distal 
tumors or strictures. 
2. Three phase McKeown’s Operation: The third incision, apart from the thoracotomy 
and laparotomy, is placed in the neck to achieve a cervical anastomosis. This 
technique is preferred for proximal tumors. 
3. Trans-hiatal Orringer’s Operation: Here 2 incisions are made, a laparotomy and a 
cervical incision. This is usually adopted in lower oesophageal lesions. The lower 
portion of the oesophagus is mobilized via the laparotomy under direct vision through 
the diaphragmatic hiatus. The upper part of the oesophagus is mobilized through the 
cervical incision by blunt dissection. This technique obviated the need for a 
thoracotomy and the accompanying morbidity. 
In strictures of the oesophagus secondary to corrosives or other etiologies, a bypass 
conduit is created using the stomach, colon or jejunum. This may be combined with an 
oesophagectomy. Proponents of oesophagectomy cite risk of malignancy, mucocele 
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formation and GERD as the reasons for resection. The counter argument to it is the 
possibility of dense peri-oesophageal adhesions resulting in tracheal injury, nerve 
injury, chyle leak etc. while attempting a resection.  
Out of the three possible conduits colon, stomach and jejunum are favored 
in that order. The jejunum is least preferred due to short length and 
precarious vascularity. In many cases, concurrent gastric injury may occur 
following caustic ingestion, thereby making it unsuitable for use as a 
conduit. The colon is generally preferred as it has shown good results in 
terms of definite vascularity and luminal size match. 
 
2.5 COMPLICATIONS FOLLOWING AN OESOPHAGECTOMY: 
NON ANASTOMOTIC 
COMPLICATIONS: 
 
 Pneumonia 
 Arrhythmia  
 Wound infection  
 Empyema/effusion 
 Reintubation 
 Ventilator dependence  
 Urinary tract infection  
 Deep venous 
thrombosis/pulmonary embolus  
 Wound dehiscence  
 Recurrent laryngeal nerve injury 
 Myocardial infarction  
 Stroke  
 Chylothorax 
 Pancreatitis  
 Pericardial effusion 
ANASTOMOTIC 
COMPLICATIONS: 
 
 Anastomotic leaks 
 Anastomotic strictures 
 Tracheo-oesophageal fistula 
secondary to leaks 
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2.6 DRAWBACKS OF CONTRAST STUDIES: 
Upper GI contrast studies were practiced routinely after an oesophageal anastomosis 
to assess occult leaks. However, this practice has been falling out of rote gradually, 
due to the low sensitivity and high false negative rates which fail to predict late leaks. 
Apart from this, the 2 contrast materials used – Barium sulfate and Gastrografin – are 
accompanied by their own adverse reactions. 
Barium, when aspirated into the airway tract remains there indefinitely and can 
predispose to granulomatous inflammation. Extravasation of barium into the 
peritoneal cavity can induce peritoneal reaction, associated with formation of 
granulomas and adhesions. Hence, Gastrografin is preferred to detect peritoneal leaks. 
However, aspiration of Gastrografin into the airway can cause pulmonary edema due 
to the hypertonicity. 
Bearing in mind the low pick up rates of these contrast studies, it is questionable as to 
whether the routine use of these studies is warranted. This trial was carried out to 
assess the same. 
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3.0 AIM: 
To assess the requirement of a routine upper GI contrast study post-operatively in 
patients undergoing an oesophageal anastomosis. 
 
3.1 PRIMARY OBJECTIVES: 
1. To assess the delay in starting oral feeds, liquids and solids between the two 
groups. 
2. To compare duration of post-operative hospital stay between the two groups. 
3. To compare the re admission rates or re-surgery rates between the two groups. 
 
3.2 SECONDARY OBJECTIVES: 
1. To evaluate the overall morbidity and 30 day mortality in the two groups. 
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4.0 LITERATURE REVIEW: 
Oesophageal and gastric cancers rank among one of the most common malignancies 
in India. In Asia, gastric cancer is the second-most common malignancy among men 
the third most common malignancy among females.(8) Oesophageal cancer is the 
eighth most common malignancy worldwide. (9)  
On assessing trends of oesophageal and gastric cancers in India, there is a rising 
incidence of oesophageal malignancies and a relative, gradual decline in the incidence 
of gastric cancers.(10) Since this study included patients who had sustained upper GI 
injuries secondary to corrosive ingestion, incidence of the same was also assessed. 
India has a higher incidence of acid ingestion than alkali.(11) 
 
4.1 RISK FACTORS FOR OESOPHAGEAL AND GASTRIC CANCERS: 
Oesophageal and gastric cancers have a time tested and scientifically proven 
association with tobacco usage in various forms. In India, the different forms of 
tobacco usage include smoking cigarettes and bidis as well as chewing it as quid.(12) 
The incidence of oesophageal cancer was higher than oral cancer in tobacco chewers 
which was attributed to the practice of swallowing the liquid extract.(12) It was also 
detected that betel nut chewing without tobacco conferred an independent risk of 
developing malignancies of the aero-digestive tract including the oesophagus.(12) 
Another risk factor associated with upper gastrointestinal malignancies was alcohol 
consumption, with arrack consumption conferring the highest risk. (12) Acetaldehyde, 
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a byproduct of alcohol acts as a carcinogen and the synergistic activity of tobacco and 
alcohol consumption had a higher risk of developing cancer.(13) Other aetiological 
associations of gastric cancer include Helicobacter pylori infection, dietary and 
lifestyle associated factors like consuming salted tea, pickled food, rice intake, spicy 
food, soda additives in diet etc.(8) 
The two most common malignancies encountered in the oesophagus are squamous 
cell carcinoma and adenocarcinoma. The incidence of squamous cell carcinoma is 
higher than that of adenocarcinoma and adenocarcinomas are more common in the 
lower one-third of the oesophagus in a setting of Barrett’s oesophagus. Gastric 
malignancies are most commonly adenocarcinomas.(14) Gastro-oesophageal junction 
tumors are a special subset with unique properties and are mostly adenocarcinomas. 
 
4.2 NATURAL HISTORY OF OESOPHAGEAL CANCER: 
At presentation, many patients have locally or regionally advanced disease because of 
the lack of a serosal layer. One other reason is the rich submucosal lymphatic network, 
which results in local infiltration and rapid spread to loco-regional lymph nodes. The 
most common sites of distant disease are the lungs, liver and bones. The predictive 
factors for tumor dissemination include depth of tumor invasion and lymph node 
involvement.(14) 
The median survival after an oesophagectomy for localized disease is 15 – 18 months. 
The overall 5 year survival rate after operation is 20– 25%. The patterns of failure 
depend on the location of the tumor as well as the histopathology. Tumors located in 
the upper two-thirds, which are predominantly squamous cell carcinomas, recur as 
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loco regional recurrences. Tumors located in the lower one-third, which are 
predominantly adenocarcinomas, recur with distant metastasis. Neo-adjuvant therapy 
in oesophageal cancers is shown to alter the patterns of failure as opposed to upfront 
surgery alone. (14) 
 
4.3 CLINICAL PRESENTATION AND PREOPERATIVE EVALUATION OF 
OESOPHAGEAL CANCER: 
The most common presentations of oesophageal cancer are dysphagia, which may 
signify locally advanced disease and weight loss. The dysphagia is usually 
progressive, with initial difficulty in swallowing solids followed by liquids. There 
may be past history of tobacco or alcohol abuse. Weight loss occurs in 90% patients 
and is associated with the dysphagia. Odynophagia, dull retrosternal pain, bone pains, 
cough etc. may signify metastatic disease.(15) 
Preoperative evaluation includes an upper GI endoscopy and biopsy as a means of 
establishing diagnosis. Chest radiography and a contrast enhanced computed 
tomogram are also performed to delineate the site of disease, extent of disease and to 
stage it. FDG-PET (Fluorodeoxyglucose Positron emission tomography) scans are 
also being widely used to stage lymph nodal disease and distant metastasis. It also 
helps to assess response to neo-adjuvant therapy.(15) 
 
4.4 TNM STAGING OF OESOPHAGEAL CANCER: 
TNM staging system has been used for oesophageal malignancies, based on the 7
th
 
Edition of AJCC (American Joint Committee for Cancer) Classification(16)  
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T stands for primary tumor, N for nodal status and M for metastasis.  
According to AJCC 7
th
 edition: 
PRIMARY TUMOR (T): 
Tx Primary tumor cannot be assessed 
T0 No evidence of primary tumor 
Tis High grade dysplasia – all non-invasive neoplastic 
epithelium 
T1 T1a – Tumor invades lamina propria or muscularis 
mucosae 
T1b – Tumor invades submucosa 
T2 Tumor invades muscularis propria 
T3 Tumor invades adventitia 
T4 T4a – Tumor invades resectable adjacent structures 
like pleura, pericardium or diaphragm 
T4b - Unresectable tumor invading structures like 
trachea, aorta or vertebra bodies 
REGIONAL LYMPH NODES (N): 
Nx Regional lymph nodes cannot be assessed 
N0 No regional lymph nodal metastasis 
N1 Regional lymph nodal metastasis involving 1-2 nodes 
N2 Regional lymph nodal metastasis involving 3-6 nodes 
N3 Regional lymph nodal metastasis involving 7 or more 
nodes 
DISTANT METASTASIS (M): 
M0 No distant metastasis 
M1 Distant metastasis 
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4.5 NATURAL HISTORY OF GASTRIC CANCER: 
95% of gastric cancers are adenocarcinomas. Spread of gastric cancers can occur by 
local extension into adjacent organs, lymphatic spread, peritoneal spread and distant 
metastases. Tumor penetration through the serosa increases the incidence of local 
extension. Surgical resection is the cornerstone treatment for patients with localized 
gastric cancer.  
4.6 CLINICAL PRESENTATION AND PREOPERATIVE EVALUATION OF 
GASTRIC CANCER: 
Symptoms of gastric cancer are vague and non-specific which end in many patients 
being diagnosed with advanced disease at presentation. The constellation of symptoms 
vary from anorexia, fatigue, weight loss, epigastric discomfort or pain, early satiety, 
heart burn and indigestion. Around 4-17% may be asymptomatic.(17) There may be 
past history of peptic ulcer disease. Ascites, jaundice and a palpable mass at 
presentation point to an incurable disease.  
Preoperative evaluation is carried out by endoscopy and biopsy for tissue diagnosis. 
Chromo endoscopy, magnification endoscopy, narrow band imaging and confocal 
laser endomicroscopy increase diagnostic accuracy, sensitivity and specificity. (15) 
 
4.7 TNM STAGING OF GASTRIC CANCER: 
According to the AJCC staging system,  
PRIMARY TUMOR (T): 
Tx Primary tumor cannot be assessed 
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T0 No evidence of primary tumor 
Tis Carcinoma in situ – not invading lamina propria 
T1 T1a – Tumor invades lamina propria or muscularis mucosae 
T1b – Tumor invades submucosa 
T2 Tumor invades muscularis propria 
T3 Tumor penetrates sub-serosal connective tissue without 
invading visceral peritoneum or adjacent structures. 
T4 T4a – Tumor invades visceral peritoneum 
T4b – Tumor invades adjacent structures 
REGIONAL LYMPH NODES (N): 
Nx Regional lymph nodes cannot be assessed 
N0 No regional lymph nodal metastasis 
N1 Regional lymph nodal metastasis involving 1-2 nodes 
N2 Regional lymph nodal metastasis involving 3-6 nodes 
N3 N3a - Regional lymph nodal metastasis involving 7 -15 
nodes 
N3b - Regional lymph nodal metastasis involving 16 or more 
regional nodes 
DISTANT METASTASIS (M): 
M0 No distant metastasis 
M1 Distant metastasis 
 
4.8 CLINICAL PRESENTATION AND PREOPERATIVE EVALUATION OF 
CORROSIVE INJURIES:  
Corrosive ingestion, resulting in oesophageal strictures is rare in adults. The 
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commonest presenting feature is dysphagia. Most of these cases are managed 
conservatively with periodic and repeated dilatations. However, in oesophageal 
strictures secondary to third degree esophageal burns, surgical intervention may be 
required.  
Preoperative preparation includes contrast studies to assess the length of the strictured 
segment, an upper GI endoscopy to assess the highest point of start of stricture and if 
possible to attempt dilatation etc. Nutritional rehabilitation, usually with feeding 
procedures like jejunostomies play a significant role pre-operatively. 
 
4.9 HISTORY OF OESOPHAGEAL RESECTIONS: 
Oesophagectomy remains the gold standard for curative or palliative therapy in 
oesophageal cancers. (10) The earliest recorded reports of esophageal surgery are 
descriptions of removal of foreign bodies lodged in the oesophagus in the 6
th
 century 
A.D. (10) In 1877, Czerny, under the tutelage of Bilroth, performed the first cervical 
oesophageal resection with re-anastomosis in humans.(18) Dobromysslow(1901) 
reported the first intrathoracic segmental oesophageal resection with primary 
anastomosis.(19) All the early reports of oesophageal surgeries were associated with 
high morbidity and mortality, primarily due to anastomotic complications.  
Torek in 1913 performed a transthoracic oesophagectomy. His patient survived 11 
years, but with a plastic tube connecting the oesophagus to the stomach. Oesophageal 
reconstructions were deemed to cause the morbidities associated with the operations. 
In 1907, Roux proposed using a jejunal segment as a substitute and Kelling in 1911 
proposed the use of colon as an oesophageal substitute. (19)  
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The first neck oesophagogastrostomy was proposed by Kirschner in 1920. 
Transthoracic oesophagogastrostomy was performed by Adams and Phemister in 
1938. All the anastomosis were hand sewn. 
The most common techniques in use today for an oesophageal resection include 
removal of the oesophagus with concurrent lymphadenectomy, in keeping with 
oncological principles. 
In 1946, Ivor-Lewis performed the first successful oesophagectomy via a combined 
thoraco-abdominal approach. He approached the stomach through a laparotomy and 
the oesophagus through a right thoracotomy, effectively creating an oesophago-gastric 
anastomosis in the thorax.(20) A natural progression of this surgery was the 
McKeown’s oesophagectomy. Here, following resection of the thoracic oesophagus, 
the tubed stomach is brought up into the neck, where it is anastomosed to the stump of 
the cervical oesophagus. The advantage offered by this procedure is that growths in 
the upper oesophagus could be resected. Furthermore, a safe, relatively easier 
anastomosis is performed in the neck, circumventing the dreaded complication of 
mediastinitis in case of an anastomotic leak.(20) 
Trans-hiatal Oesophagectomy – without a thoracotomy was proposed by Orringer in 
1978, primarily to avoid the physiological insult of a thoracic and abdominal incision 
and to avoid mediastinitis secondary to a leak in the thoracic cavity.(21) 
Today, oesophagectomies are being carried out with lesser complications and better 
outcomes. The frontiers of oesophageal surgery are being pushed further and further 
by the advent of stapling devises, newer energy sources which aid in dissection and 
minimally invasive surgery. 
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4.10 SURGICAL OPTIONS FOR CORROSIVE INJURIES OF THE 
OESOPHAGUS: 
Stricture formation remains the most common long term complication following 
corrosive ingestion in individuals who do not succumb to the acute complications. 
Around 90% of patients with third degree burns and 15 - 30% of patients with second-
degree burns develop strictures.(22) Most patients with strictures are initially managed 
with dilatations, but many require several sittings and always carry a risk of 
perforation with subsequent fatal mediastinitis. Moreover, repeated dilatations are 
seen as procrastination in these individuals who continue to have dysphagia, aspiration 
and starvation. This is where surgical bypass procedures using different visceral 
conduits step in. 
Surgeries performed for an oesophageal stricture aim at restoring intestinal continuity 
either via a colon pull through or a gastric pull through. A colon pull through is more 
commonly employed due to the possible concurrent gastric injuries caused by the 
corrosive ingestion. An oesophagectomy may or may not be performed as an 
adjunctive procedure for a colon pull through. 
When considering a gastric pull through, lesser anatomical changes and a single 
cervical anastomosis make it an attractive option. But prior to the surgery it is 
mandatory to assess the gastric anatomy either by a contrast radiograph or via a 
Contrast Enhanced Computed Tomogram. Since lymphadenectomy is not required 
while performing an oesophagectomy in corrosive strictures, a thoracotomy can easily 
be avoided by doing a trans-hiatal dissection.(22) 
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When treating corrosive oesophageal strictures with surgical intervention, the question 
of whether or not oesophageal resection is required needs to be considered and is still 
a controversy.(23) The argument against leaving behind the strictured portion of the 
oesophagus is the risk of developing scar carcinoma in the future, the incidence of 
which has been reported to be around 7.2%.(24) 
In cases of complete strictures, there may be a lesser incidence of malignant 
transformation since no further irritation occurs. In such cases an oesophageal 
exclusion is advocated.(25) In cases undergoing oesophageal resection, dense tissue 
adhesions may theoretically produce higher incidence of complications like tracheal 
injuries, recurrent laryngeal nerve injuries causing vocal cord palsy, poor healing at 
the anastomotic site etc. However, oesophageal resection along with bypass 
procedures has been recommended as the operation of choice in the following set of 
patients: 
1) If the stricture is tight enough to require reconstructive surgery, 
2)  If there is any finding suggestive of malignancies such as long duration of the 
lesions of more than 30 years, or mass-like lesions on endoscopy,  
3) Sudden aggravation of preexisting dysphagia. 
The surgical options available are substernal oesophageal bypass surgery without 
oesophagectomy and oesophageal resection with replacement surgery through 
thoracotomy. 
The conduits available for oesophageal reconstruction are the stomach, if there are no 
corrosive injuries, the jejunum and the colon. They are sited either in a substernal 
location or subcutaneously. The gastric conduit is based on the right gastro-epiploic 
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and right gastric arteries. The colon is reserved for cases where the stomach is deemed 
unsuitable due to concomitant strictures of the stomach. The right colonic conduit is 
based on the ascending branch of the right colic artery and the left colonic conduit is 
based on the left branch of the middle colic artery. In all cases of colonic conduits the 
assessment of vascularity is mandatory. This is performed by occluding the meso-
colic vessels which have been slated for division with bull dog clamps and assessing 
the vascularity of the conduit prior to division. A colonic transposition changes the 
gastro-intestinal anatomy more than a gastric conduit. This includes delayed 
complications like stenosis at the anastomotic site.  
In spite of advances and good outcomes in oesophageal bypass procedures, the 
management of proximal strictures, like those at the level of the oropharynx or 
cricopharynx continue to present a challenge. Any surgical interventions at this level 
interfere with deglutition mechanisms.(26) 
 
4.11 COMPARISON BETWEEN HEALING IN SKIN WOUNDS AND 
GASTROINTESTINAL TRACT: 
Effective and quick wound healing is of immense importance in gastrointestinal 
surgery and especially in gastrointestinal anastomosis. Failure at any point in the 
myriad steps of wound healing translates into prolonged hospitalization, life 
threatening complications, added monetary burden, and long term disabilities to the 
patient.(27) Hence, an overview of the factors involved in healing plays a role of 
paramount importance in understanding the background of anastomotic leaks. 
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4.12 CLASSICAL WOUND HEALING: 
The classical pathway of wound healing involving the 3 phases has been classically 
described in skin injuries. This pathway follows a cycle of: 
1. Inflammation or lag phase (2-3 days): The healing cascade kicks off with the 
formation of a platelet plug followed by increased vascular permeability resulting in 
an influx of inflammatory cells. The neutrophils, which are the first responders, rid the 
wound off all pathogens which triggered the inflammatory activity. This is soon 
followed by an influx of monocytes and tissue macrophages, which in turn secrete 
many growth factors. 
2. Proliferative phase: This is heralded by the arrival of fibroblasts. The major 
portion of wound healing begins here with the various growth factors mediating the 
activity of the fibroblasts. The collagen in a healing wound is predominantly type III 
as opposed to type I collagen which is normally seen. Angiogenesis also takes place 
now, thereby ensuring adequate oxygenation to the healing areas, along with an influx 
of all the nutrients and supplementary growth factors. 
3. Remodeling phase: This phase is characterized predominantly by wound 
contraction, reduction in the number of fibroblasts and a fall in the amount of type III 
collagen. (27) 
 
4.13 HEALING IN THE GASTROINTESTINAL TRACT: 
Healing in the gastrointestinal tract has the disadvantage of taking place in obscurity, 
where the surgeon goes by the patient’s general well-being, laboratory parameters and 
radiological aids, to judge the healing process and thus intervene appropriately. The 
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process of healing in the gastrointestinal tract differs from general wound healing in a 
few key points. 
Unlike skin, the gastrointestinal tract has four layers (mucosa, submucosa, muscularis 
propria, and serosa) which all contribute to healing. Halstead, proposed that the 
majority of strength in a GI anastomosis is provided by the submucosa.(28) There are 
3 types of collagen (I, III and V) which aid in wound healing here, all of which are 
maximally concentrated in the submucosa. The serosa of the bowel forms a barrier, 
which on approximation, reduces the incidence of leaks. Absence of this layer in some 
portions of the gastrointestinal tract, like the oesophagus and the rectum, contributes 
an added risk to the anastomosis.(28) 
The healing of an anastomosis in the initial few days, depends on the strength of the 
suture material or stapler used. During the same period, there is activation of 
inflammation, which produces collagenases resulting in breakdown of collagen in the 
region. This contributes to a weakness in the anastomosis. The maturation of the 
anastomosis occurs soon after as a result of formation of thick bundles of mature 
collagen. 
 
4.14 VARIATIONS BETWEEN SKIN AND GASTROINTESTINAL HEALING: 
Healing in the skin and gastrointestinal tract, although occurring along the same 
general principles, deviates in certain other ways. The rate of wound healing in a GI 
anastomosis is more rapid than in skin. It occurs in weeks as opposed to months. 
However, this rapidity in healing is partially contributed by the serosal layer which 
forms a physical barrier, the absence of which weakens anastomotic integrity.(28) 
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Other factors which adversely affect the gastrointestinal anastomosis are the 
bioburden of aerobic and anaerobic organisms, the shear stresses over the wound and 
the precarious vascularity. The predominant determinant among these is vascularity, 
which gets downregulated secondary to hypotension causing hypo perfusion of the 
anastomosis. (19) Yet another significant factor threatening an anastomosis is the 
increased collagenase activity which further acts to weaken the healing wound. 
 
4.15 FACTORS INFLUENCING ANASTOMOTIC HEALING: 
A gastrointestinal anastomosis is the weakest at the beginning of the wound healing 
process due to the collagenase activity. At 48 hours the strength of the anastomosis 
weakens by 40% due to this. Once proliferation and remodeling begin, the 
anastomosis starts gaining strength. (27) During this period the anastomosis is at risk 
of giving way since the bursting pressure is at its lowest. (Bursting pressure is defined 
as the maximal intraluminal pressure which will result in the anastomosis giving 
way.)(27). 
There are two major factors which determine the successful healing of any wound, 
including a gastrointestinal anastomosis. These are commonly categorized as local 
factors and systemic factors. In cases, where an oesophageal anastomosis is involved 
there are a third set of “inherent factors” that add a unique dimension which plays a 
vital role in the healing of the anastomosis and plays a role in the anastomotic leaks, 
which can be devastating or even fatal, in an oesophagectomy. 
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4.15.1 SYSTEMIC FACTORS: 
The major systemic factors influencing healing are: 
1. Nutrition 
2. Sepsis 
3. Immuno-compromise secondary to diseases, medication etc. 
4. Fluid depletion and shock 
5. Poor glycemic control and other metabolic disorders 
6. Alcoholism 
7. Compromised liver disease 
8. Chemotherapy 
4.15.2 LOCAL FACTORS: 
The local factors involved in healing are: 
1. Local infection 
2. Mechanical factors like poor apposition, excessive mobility etc. 
3. Foreign bodies 
4. Size, location and type of wound 
5. Technical errors 
6. Gastric compression 
7. Compromised vascularity 
8. Conduit ischemia 
9. Tension across the anastomotic junction 
10.  Distal obstruction 
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4.16 COMPLICATIONS OF AN OESOPHAGEAL ANASTOMOSIS: 
The complications following an oesophagectomy and oesophageal anastomosis can be 
broadly divided into those related to the anastomosis and those, which are not.  
The non-anastomotic complications include pulmonary infections, pleural effusion, 
thoracic duct injury with chyle leak and chylothorax, cardiac arrhythmias, recurrent 
laryngeal nerve injury, postoperative venous thromboembolism etc. Out of these 
complications, pulmonary complications form the major burden and can be as high as 
44% to 46% incidentally.(29) 
Anastomosis related complications form a major bulk of post-operative morbidity 
and even mortality.(30) They have significantly decreased over decades but still form 
a major burden. This decrease in incidence is attributed to a better knowledge of 
anatomy, refined anastomotic techniques and modern perioperative care.(30) 
Anastomosis related complications include bleeding with hematoma formation, 
anastomotic leaks, and wound infections secondary to a leak etc., in the short term 
followed by strictures or disease recurrence in the long term.(31) Out of all these, 
leaks form the bulk of the most serious and lethal acute complication of an 
oesophageal anastomosis. 
4.17 OESOPHAGEAL ANASTOMOTIC LEAKS: 
4.17.1 DEFINITION: 
The incidence of anastomotic leaks following oesophageal cancer resection can range 
as high as 17% and is accompanied by a mortality of up to 60%.(32) A literature 
review of the definition of an anastomotic leak spans a wide spectrum from clinical 
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definitions to those confirmed by radiological imaging or at re-operation. This lack of 
a consensus in definition skews the available data on incidence of anastomotic leaks. 
Some of the common definitions are reviewed here: 
Young Lee (1994):  
An anastomotic leak is defined as having (1) necrosis, (2) a major leak with clinical 
manifestations requiring surgical repair, (3) a major leak which spontaneously healed, 
and (4) a minor leak (a "radiological leak").(33) 
Urschel (1995): 
 A post oesophagectomy anastomotic leak is a radiologically or clinically apparent 
oesophago-gastrostomy anastomotic dehiscence.(32) 
Ihabb I. El Hajj (2014):  
Leaks were defined as postoperative dehiscence of the peri-anastomotic region.(34) 
Surgical Infection Study Group (1991):(35) 
LEAK DEFINITION 
Radiological No clinical signs 
Clinical minor -Local inflammation at the neck wound 
-X-ray showing contained leak 
-Fever, leukocytosis, elevated CRP 
Clinical major -Severe disruption on endoscopy 
-Sepsis 
Conduit 
necrosis 
-Endoscopic confirmation 
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As a consensus, an anastomotic leak includes a hematoma or seroma at the neck 
wound, septicemia, peritonitis, peri-anastomotic collection, local inflammation, 
evacuation of air or saliva from the wound, mediastinitis, abscess, empyema and 
pneumothorax.(30) 
 
4.17.2 RISK FACTORS FOR AN OESPHAGEAL ANASTOMTOIC LEAK: 
The systemic and local factors influencing healing of an anastomosis along with a 
brief overview of the factors inherent to an oesophageal anastomosis have already 
been reviewed earlier. Out of the systemic factors involved hypertension and elevated 
creatinine (>0.85 mg/dl) were found to be independent risk factors for a cervical 
anastomotic leak. (28) This was attributed to poor tissue micro perfusion. 
The factors influencing an oesophageal anastomosis will be reviewed in detail here. 
The properties exclusively inherent to an oesophageal anastomosis include(32): 
1. Absence of serosa 
2. Extra-peritoneal nature of the structure 
3. Longitudinal muscle coat which holds sutures poorly 
4. Technically awkward suturing 
5. Difficult reconstructive techniques requiring extensive mobilization of conduits. 
Furthermore, the factors which can possibly influence an oesophageal anastomosis are  
1. The tumor histology, stage and location of the tumor,  
2. The organ used as an oesophageal conduit and intra-operative factors,  
3. The technique and location of anastomosis (cervical or intrathoracic),  
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4. Single Vs. double layer suturing,  
5. Manual suturing Vs. mechanical stapling,  
6. Distance between the anastomosis line and the tumor,  
7. Microscopic involvement of surgical resection margins,  
8. Neo-adjuvant radiotherapy or chemotherapy.(36)  
 
1. THE TUMOR HISTOLOGY, STAGE AND LOCATION OF THE TUMOR: 
It has been reported that factors pertaining to the tumor like the histology, size and 
location do not adversely influence the leak rates. However, the tumor differentiation 
could increase the incidence of a leak, with poorly differentiated tumors having a 
higher leak rate.(36)  
2. THE ORGAN USED AS AN OESOPHAGEAL CONDUIT AND INTRA-
OPERATIVE FACTORS: 
Intra-operative factors which can affect an anastomosis adversely are intra-operative 
hypotension which has a negative effect on the tissue perfusion and oxygenation.  
The conduits commonly used as oesophageal substitutes are the stomach, colon and 
jejunum, in that order of preference. The stomach conduit is based on the right 
gastroepiploic vessels. The significance of this anatomical fact, is that approximately 
60% of the gastric tube is supplied by this vessel, the cranial 20% is supplied by 
minute connections between right and left gastroepiploic vessels and the most cranial 
20% is vascularized through a dense submucosal and microvascular network. Since 
the oesophago-gastric anastomosis is constructed at the proximal 20% of the gastric 
fundus, any trauma in the form of application of suction devices, traction sutures to 
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facilitate the gastric pull-up maneuver etc. can predispose to anastomotic leaks.(37) A 
tension free anastomosis, especially if the proximal portion with doubtful vascularity 
is resected, can be ensured by performing a Kocher’s maneuver and pulling up the 
gastric tube.(38) 
The colon has a more consistent vascularity and in high volume centers the outcomes 
between gastric conduits and colonic conduits in terms of complications are almost 
identical. The jejunal conduit has the most precarious vascularity of the three conduits. 
This is attributed to the technical difficulty involved in creating a sufficiently long 
tube which will not kink or compromise the vascularity. (37) 
Gastric distension, postoperatively can predispose to a leak and is circumvented by 
doing a pyloroplasty or pyloromyotomy to facilitate easier drainage.(39) But the 
drawback of this procedure in the long risk is the possibility of duodeno-gastric reflux 
causing delayed anastomotic stricture and Barrett’s metaplasia. 
3. THE TECHNIQUE AND LOCATION OF ANASTOMOSIS (CERVICAL OR 
INTRATHORACIC): 
The technique of oesophageal resection, trans-hiatal versus transthoracic and the 
incidence of anastomotic leaks in each, continues to be under debate. 2 randomized 
controls were performed by Goldminc et al(40) and Chu et al(41) which failed to 
prove any differences in outcomes. This was followed by an analysis carried out by 
Papenfuss et al. They concluded that serious morbidity remains clinically significant 
in both groups. But the group undergoing trans-hiatal oesophagectomies had a 
significantly higher superficial wound infection rate while the group undergoing trans-
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thoracic oesophagectomies required more perioperative blood transfusions and higher 
re-operation rates.(42) 
4. SINGLE VS. DOUBLE LAYER 
The construction of an oesophageal anastomosis can be single layered or double 
layered. The single layered technique for bowel anastomosis was proposed by Halsted 
in the 19
th
 century(43). This was countered by Czerny in 1880 who proposed double 
layered suturing.(44). This century old debate was laid to rest by a Cochrane review 
article in 2012 which did not demonstrate any appreciable differences in outcomes 
between these two groups.(45) 
5. MANUAL SUTURING VS. MECHANICAL STAPLING: 
The progressive fall in complications following an oesophagectomy has been 
attributed to advances in operative techniques and perioperative care. One of the 
newer advances is the use of circular staplers to perform the oesophageal anastomosis. 
The stapling device is said to be less traumatic, consumes less operating time and has 
an easier learning curve.(46) A prospective randomized control trial conducted by Liu 
et al.(46) cited that staplers were superior to hand-sewn anastomosis in terms of 
preventing anastomotic leaks but on follow up, were associated with a two-fold 
increase in stricture rates. A meta-analysis by Wang et al. in 2015 concluded stating 
that there were no difference in complication rates between the two techniques. But 
they also summarized that staplers were more cost effective and associated with 
shorter hospital stays. (47) The higher rate of stricture formation is caused by a lack of 
accurate mucosa-to-mucosa apposition, tissue necrosis beyond the staple line and the 
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non-absorbable staplers which prevent the lumen from dilating more than the original 
size. All these factors are negated in a hand sewn anastomosis.(47) 
6. COMPARISON OF LEAKS IN CERVICAL AND THORACIC ANASTOMOSIS: 
The leak rates between cervical and thoracic anastomosis gain significance as the 
morbidity and mortality rates between the two vary. Cervical leaks are associated with 
less morbidity and mortality as compared to intra-thoracic leaks. The higher incidence 
of cervical leaks has been explained by a multitude of reasons like tension across the 
anastomosis due to longer length of the conduit, extrinsic compression, and the non-
mesothelial environment of the neck. (48) The relative safety of a cervical leak lies in 
the propensity for early detection, feasibility of bedside drainage procedures etc. 
Recent studies fail to demonstrate a definitive higher incidence but have proven that 
cervical anastomotic leaks are associated with lower mortality rates than thoracic 
leaks.(49) 
7. MICROSCOPIC INVOLVEMENT OF SURGICAL RESECTION MARGINS: 
Oesophageal cancer has a well-recognized tendency to spread intra-murally as well as 
have multiple separate lesions at the same time. This phenomenon contributes to the 
microscopic involvement of the resection margins. Though, theoretically this can 
predispose to higher incidence of anastomotic leaks, the issue remains controversial. 
There are studies which support the hypothesis like those by Urschel et al. (48) and 
there are articles from Simon et al (50) which refute it. Hence, the additional risk of an 
involved margin remains debatable. 
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8. NEO-ADJUVANT RADIOTHERAPY OR CHEMOTHERAPY: 
Oesophageal cancers are now as a rule tackled by multimodality treatment, even 
though surgery remains the curative option. Hence, the effect of neo-adjuvant therapy, 
chemotherapy, radiotherapy or both, on surgical outcomes needs inspection. Wolfard 
et al. in 2011 reported a higher incidence of post-operative anastomotic leaks 
following NACRT.(51) This was followed up by a meta-analysis by an European 
study group in 2014 which failed to demonstrate an increase in anastomotic leaks after 
NACRT.(52) This had been further borne out by a study published in 2015 by Hamai 
et al.(53) 
 
4.17.3 CLINICAL FEATURES OF AN OEOSPHAGEAL ANASTOMOTIC LEAK: 
The clinical presentation of an anastomotic leak following an oesophagectomy spans a 
wide spectrum ranging from asymptomatic, clinically silent leaks detected by routine 
radiology to those which present in sepsis.(48) This was decided primarily by the 
following factors: 
1. Viability of the conduit used in reconstruction 
2. Site of the leak – cervical Vs. thoracic  
3. Degree of containment of leak by surrounding tissues 
4. Time of detection and intervention. 
 
In 1995, Urschel presented a landmark paper which classified the severity of leaks 
according to the clinical presentation.(48) 
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CATEGORY OF 
LEAK 
TIME ETIOLOGY CLINICAL 
PRESENTATION 
EARLY 
FULMINANT 
<48 hours Gross 
technical 
errors 
Gastric 
necrosis 
Septic shock 
Foul chest drain output 
CLINICALLY 
APPARENT 
THORACIC 
LEAK 
2-7 days Multifactorial Sepsis 
GI contents in chest tube 
Pleural collections on 
radiography 
CLINICALLY 
APPARENT 
CERVICAL 
LEAK 
2-10 days Multifactorial Fever 
Inflamed neck wound 
Drainage via neck drain or 
neck incision 
CLINICALLY 
SILENT 
Routine 
radiograph 
on day 7 
Multifactorial Small, asymptomatic, 
clinically silent, contained 
leak 
 
4.17.4 SYSTEMIC FEATURES OF AN OESOPHAGEAL ANASTOMOTIC LEAK: 
The clinical features which would suggest a leak are: 
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 Tachycardia (heart rate > 100 beats per minute), 
 Fever (body temperature > 38°C), 
 Tachypnea (high respiratory rate), > 20 breaths  per minute 
 Leukocytosis (> 12 × 103/ml) 
 
4.17.5 LOCAL FEATURES: 
CERVICAL ANASTOMOTIC LEAKS: Localized swelling, erythema, 
tenderness, subcutaneous emphysema, purulent discharge and halitosis or oral feeds 
expelled from the neck wound are features suggestive of a cervical anastomotic 
leak.(54) 
THORACIC ANASTOMOTIC LEAKS: Pleural effusion, shortness of 
breath, chest pain, atrial dysrhythmias, bilious drainage from the chest tube, hydro-
pneumothorax, vomiting and subcutaneous emphysema over the chest wall or neck 
may point at an intra-thoracic anastomotic leak.(55) 
ABDOMINAL LEAKS: In total gastrectomies, the oesophago-jejunal 
anastomosis is sited in the peritoneal cavity. These leaks, along with the systemic 
features can present with peritonitis and expulsion of intestinal contents in the drain. 
4.17.6 CLINICAL PREDICTORS OF SEVERITY OF AN OESOPHAGEAL 
ANASTOMOTIC LEAK: 
The severity of an oesophageal leak can be predicted by certain factors 
as below: (56) 
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1. Time of manifestation: The earlier a leak occurs, it’s more likely 
to be secondary to technical errors or conduit necrosis. In such a scenario, lack of time 
for the surrounding tissues to contain the leak results in higher morbidity. 
2. Leaks with clinical manifestation: This again is attributed to lack 
of surrounding tissue reaction, which fails to contain the leak. 
3. Leaks requiring surgical intervention: In individuals where 
operative intervention is performed for an anastomotic leak, mortality risks increase. 
This is evidently in direct proportion to the severity and florid nature of the leak. 
4. Conduit necrosis: Gastric necrosis has been reported as the only 
unequivocal predictor of mortality secondary to esophageal leaks. This complication 
is associated with a large defect that leaks freely into the exterior in cases of cervical 
anastomosis. The same leak in an intra-thoracic anastomosis can be lethal. In worst 
case scenarios, the foregut continuity may be lost secondary to conduit necrosis.(56) 
5. Delayed diagnosis: Failure to detect a leak or failure to deal 
aggressively with it after diagnosis, have been proven to have poorer outcomes. 
 
4.18 HISTORY OF UPPER GI CONTRAST STUDIES: 
The concept of visualizing the upper gastrointestinal tract by using 
radio-opaque materials was heralded by Dr. Cannon who initiated the development of 
upper GI contrast study series by his studies on a goose. He observed the passage of 
bismuth sub nitrate impregnated grains through the gullet of a goose using Roentgen 
rays.(57) The first radio-opaque foreign body to be detected within the oesophagus 
was an iron staple in the year 1898 by Bliss.(58). Following these papers, radiological 
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evaluation of the gastrointestinal tract grew from the basics to the sophisticated 
modalities available today. 
Different preparations and formulations of barium sulfate were then 
investigated through the ages for their efficacy in opacifying the gastrointestinal tract 
and offering improved delineation of mucosal details also.(59) As a natural 
progression of events Brombart et al described the use of barium sulfate solution to 
study oesophageal anatomy. This was translated to the use of the solution to identify 
oesophageal tears or perforations and further studies went on to assess the effects of 
the chemical on the mediastinum and the peritoneal cavity.(60) Himmelman in 1933 
pronounced barium sulfate to be harmful to the peritoneal cavity. This was further 
proved by Thomas et al who proved the pathology behind the inflammation and the 
formation of barium granulomas with adhesions as the final outcomes. This was 
followed by papers which advocated the use of laparotomy and peritoneal lavage if 
barium extravasated into the peritoneal cavity following swallow studies or enemas. 
Christofordis, Reich and Andrews et al individually published results to 
prove that unlike the peritoneal cavity, barium was less harmful to the mediastinum 
and lungs than aqueous contrast media.(60) This was attributed to the transient 
mechanical blockage caused by barium on aspiration. Whereas, when hypertonic 
water soluble contrast media enter the lungs or mediastinum, it is more distressing 
than barium, with aspiration resulting in pulmonary edema.(61) 
Vessal et al, in 1975, published his work on assessing the usefulness of 
aqueous contrast media like Gastrografin as compared to contrast media like Barium 
sulfate. He aimed at assessing the efficacy of either material as well as the deleterious 
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effects of both in case of mediastinal or peritoneal extravasation in cats. His 
recommendations advocated the use of aqueous contrast media to delineate distal 
oesophageal tears followed by the use of barium in cases of a negative study for 
confirmation.(60) 
All the above proved the superiority of barium sulfate over Gastrografin 
in detecting anastomotic leaks. It also laid down the guidelines that barium was safe to 
assess mediastinal leaks and Gastrografin to assess peritoneal leaks.  
 
4.19 TESTING THE INTEGRITY OF AN OESOPHAGEAL ANASTOMOSIS: 
After the establishment of contrast radiography to detect oesophageal 
tears and perforations it was a natural transition to use the same modality to assess 
integrity of oesophageal anastomosis after an oesophagectomy. This gained a foothold 
since the most dreaded complication of an oesophagectomy, which determined the 
outcome of the surgery, was an anastomotic leak. The recommendations were that if 
there was no evidence of aspiration, water based contrast media (sensitivity-40%) was 
used as the first line of radiography. If no leaks were detected, this was followed up 
with a barium contrast (sensitivity-60%) studies for confirmation.(61) 
The poor sensitivity of aqueous contrast media, risk of iodine induced 
anaphylaxis and pulmonary edema secondary to aspiration prompted the preference of 
barium swallows as the investigation of choice in assessing post-operative 
anastomotic leaks.(61)(62) This formed the basis of recommending a routine post-
operative upper gastrointestinal contrast study after an oesophagectomy. This practice 
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was gradually questioned after the advent of newer and safer ways of predicting leaks 
along with studies showing poor sensitivity of swallow studies.(63) 
 
4.20 CHANGE IN TREND OF UPPER GI CONTRAST STUDIES: 
One of the earliest studies questioning the use of Gastrografin in 
assessing cervical anastomotic leaks was published from AIIMS, India by A.K.Goel et 
al.(64) in 1995. They advocated the use of test feeds with saline followed by milk and 
using clinical predictors to diagnose anastomotic leaks rather than doing a 
Gastrografin swallow. They also stated that minor leaks missed by the above 
technique did not adversely affect the patients.(64) 
A paper brought out by Tirnaksiz et al. (2005)(2) assessed the 
sensitivity, specificity and positive predictive value of Gastrografin swallow in 
detecting leaks of cervical and intra-thoracic anastomosis. In cervical anastomosis, the 
sensitivity was 43.7 % and specificity was 95.4 %. In intra-thoracic anastomosis, the 
sensitivity was 30% and specificity was 94.5%. This study went on to show that the 
high specificity of Gastrografin swallow in detecting leaks, after an Ivor-Lewis 
oesophagectomy came at the price of low sensitivity. 
The study proposed discontinuation of the practice of a routine upper 
gastrointestinal contrast study for the following reasons: 
1. The risk of aspiration and pulmonary edema associated with 
Gastrografin swallow. 
  
 
 
 
43 
2. A negative study on the 7th post-operative day did not exclude the 
possibility of a delayed leak and in fact caused a complacence and delay in 
intervention with associated increase in morbidity. 
 
This was followed up with a study by Tonouchi et al.(2006)(65) who 
also pronounced that contrast studies had a sensitivity of only 50% and did not 
recommend repeat studies as confirmation. They went on to advocate the use of 
Contrast Enhanced Computed Tomograms to rule out strongly suspected leaks. 
Daniel et al in 2012(4) went on to consolidate the thought process of 
giving up routine contrast studies with Gastrografin to assess anastomotic leaks. 
Christopher et al. published a best evidence topic paper in 2015. They 
analyzed 5 major publications by Goel et al, Solomon et al, Tirnaskiz et al, Boone et 
al and Cooke et al. The bottom line of their meta-analysis was that the low sensitivity 
and positive predictive values of routinely used upper gastrointestinal contrast studies 
precluded their use as a mandatory study in patients with no clinical features to 
suggest an anastomotic leak following a cervical anastomosis.(66) 
4.21 ALTERNATIVES TO PREDICTING ANASTOMOTIC LEAKS: 
Since an oesophageal anastomotic leak still poses a challenge both in 
terms of detection and treatment, selective imaging with oral contrast study or 
alternative methods for evaluating the integrity of an oesophageal anastomosis may be 
practiced. The overall consensus, however lies in careful monitoring of clinical signs 
that suggest a leak. All other modalities are taken as adjuncts to aid in the diagnosis 
when a leak is suspected. 
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Some of the techniques described by various teams are: 
1. Contrast Enhanced Computed Tomography  
2. Test feeding 
3. Electrolyte gated method 
4. Endoscopy 
1. Contrast Enhanced Computed Tomography: 
The path to using CECT for detecting intra-thoracic anastomotic leaks 
was laid by Heiken et al(67) in 1984. This was followed by other studies assessing the 
usefulness and superiority of CECT over routine barium oesophagograms. The 
advantage offered by a CT scan over an oesophagogram is attributed to its ability to 
pick up indirect signs of a leak. These could be loculated or free fluid or gas in the 
mediastinum as in cases of sealed off leaks. However, this higher sensitivity is offset 
by a lower specificity as the above findings may be secondary to post-operative 
changes. Another added advantage is the ease of doing a CECT as compared to a 
fluoroscopic examination in very ill or less mobile patients. (68)Doing a CT study 
with oral contrast increases specificity in cases of ongoing leaks but offers no benefit 
in sealed leaks.(69) In addition, residual barium from an oesophagogram interferes 
with the interpretation of CT images due to scatter. 
Strauss et al in 2010, stated that a CECT done on post-operative day 7 
had greater sensitivity and specificity in detecting anastomotic leaks following an 
Ivor-Lewis than a contrast swallow.(70) This was further backed up by Kim et al who 
also suggested that the size of the leak, and extent of contrast extravasation could be 
pointers to the severity of the leak.(71) 
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2. Test feeding: 
There have also been descriptions of using methylene blue to detect 
intra-thoracic leaks in patients with drains in situ to detect leaks, especially in 
clinically ill patients(72)(73). 
Test feeds with water have been described, especially in detection of 
cervical anastomosis.(64) Boone et al in 2008, conducted a study to compare the 
outcomes of using water as a test feed while observing the cervical anastomosis and 
doing a routine oeosphagogram. They proved the superiority of water test feeds but 
confined their results to a cervical anastomosis only.(3) 
3. Electrolyte gated method: 
This novel technique was proposed by Dearmond et al in 2013(74). It 
has been named as the electrolyte-gated leak detection (EGLD). This test has been 
based on detection of electrical changes induced by electrolyte extravasation from a 
leak site. The electrolyte used was normal saline. This is still in the experimental 
phase but so far has shown promise with high sensitivity as well as specificity. The 
use of an inert substance like saline adds to its potential as a safe and effective 
alternative to oesophagograms.(74)  
4. Endoscopy: 
Endoscopic examination, accompanied by air insufflation, has been 
viewed skeptically because of the theoretical danger of anastomotic dehiscence, post 
oesophagectomy. Maish et al, heralded a change in this line of thinking in 2005, when 
they assessed the integrity of an oesophageal anastomosis in terms of graft ischemia, 
graft loss and anastomotic leak. The advantage quoted by their study was that, 
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following an endoscopic evaluation of the anastomosis, in clinically unwell patients, 
other causes like pneumonia, wound infection or abscess, line sepsis, pulmonary 
embolism, liver failure etc. were sought for and addressed earlier.(75)  
The added advantage is that an endoscopic evaluation allows a measure 
of freedom to intervene, in the form of stents if an early leak is detected. Furthermore, 
an endoscopic assessment is the only way to assess the viability of the conduit 
adjacent to the leak. Thus the information gained by an endoscopy can be used to 
tailor treatment to the individual.(76) 
In patients with discordant radiological findings, endoscopic evaluation 
is deemed the confirmatory test.(68) 
Fujiwara et al have gone on to advocate day 1 endoscopy to look for 
Mucosal Color Change (MCC) as an early predictor of loss of anastomotic integrity 
and poor healing of the anastomosis.(77) 
 
4.22 PRESENT KNOWLEDGE AND JUSTIFICATION OF THE STUDY: 
Thus, multiple studies have stated the drawbacks and pitfalls of doing a 
routine contrast swallow oesophagogram post operatively. Additionally, the day of 
doing the study, amount of contrast required, positioning of the patient etc. are as yet 
debated factors. 
Moreover, the low sensitivity and specificity of these studies when 
weighed against the potential dangers of aspiration, missed anastomotic leaks, delayed 
anastomotic leaks, cost of the procedure, prolongation of hospitalization etc., raise 
questions that need justification. 
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Most of the studies have been retrospective in nature and been 
conducted in developed countries. In India, where the healthcare system is burdened 
with low doctor patient ratios, inadequate health benefit packages, the use of a 
redundant imaging modality is not advisable. Hence, this study is being performed 
with the aim of phasing out a practice that offers no real time benefits but could 
potentially reduce length of stay in the hospital and the financial burden.  
If this study shows no added morbidity in patients who are not routinely 
subjected to an upper GI contrast swallow, then the routine use of this practice can be 
abandoned in those without clinical indicators of a leak. Furthermore, a protocol could 
be drawn up to compare the different indices and their sensitivity in predicting leaks. 
In those with a high suspicion of leaks, more sensitive and specific modalities can be 
employed.  
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5. MATERIALS AND 
METHODS 
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The Institutional Review Board of Christian Medical College, Vellore, reviewed this 
study in October 2013 and approved the trial in February 2014. The trial was then 
registered with the Clinical Trial Registry of India (REF/2014/04/006881). The study 
was conducted from March 2014 to June 2015.  
This was a Randomized Control Trial carried out among patients in a single General 
Surgical unit. The main factor looked at for inclusion was the presence of an 
oesophageal anastomosis. Thus, the inclusion criteria were: 
1. All patients undergoing an oesophageal anastomosis ( hand sewn or stapled) 
2. McKeown’s Oesophagectomy 
3. Ivor-Lewis Oesophagectomy 
4. Total Gastrectomy 
5. Colon bypass procedures or stomach pull through for corrosive strictures. 
6. Patients undergoing an oesophageal anastomosis and other surgeries concurrently (Ex: 
Cholecystectomy, Splenectomy etc.)  
The exclusion criteria were: 
1.  Patients refusing to participate in the study.  
2.  Pregnant ladies. 
There was no deviation from the standard pre-operative evaluation and preparation. 
The surgery plans were made after Multi-Disciplinary Tumor board meetings. The 
patients fitting the inclusion criteria were explained about the proposed study plan and 
informed written consent was obtained. Post-operatively the patients were randomized 
to two groups as follows: 
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GROUP A:  
All the patients from the Group A underwent a routine upper GI contrast study 
between post-operative days 7 to 9 in keeping with the current practice. However, if 
clinically indicated (Ex: To assess the extent of leak, to plan further course of 
management etc.) the patient may undergo a Contrast Enhanced Computed Tomogram 
scan. The decision as to whether to go ahead with a Barium or Gastrografin swallow 
or to withhold it in favor of higher, more sensitive imaging like a Contrast Enhanced 
Computed Tomogram scan was taken by the operating surgeon and the team. This was 
included as part of an intention to treat during the final analysis. 
GROUP B:  
Patients from Group B did not undergo a routine upper GI contrast study. Instead, they 
were serially monitored for the below mentioned signs of an anastomotic leak. If there 
was a clinical suspicion of a leak, they underwent a radiological imaging as per the 
discretion of the treating surgeon, which was most likely to be a Contrast Enhanced 
Computed Tomogram. The clinical features which were suggestive of a leak are: 
 Tachycardia (Heart rate > 100 beats per minute), 
 Fever (Body temperature > 38°c), 
 Tachypnea (high respiratory rate), with greater than 20 breaths per minute 
 Local or generalized peritoneal reaction during physical examination 
 Leukocytosis (> 12 × 103/ml) 
 Wound infection/discharge in case of neck anastomosis. 
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*All the above were strictly and serially monitored in these patients and presence of 
any 2 out of these was used as reliable clinical indicators of an anastomotic leak. 
 
INTERVENTION AND COMPARATOR AGENT:  
Outcomes of performing an upper GI contrast study between post-operative day 5 to 
day 7 versus no upper GI contrast study esophagogram were assessed. 
 
METHOD OF RANDOMIZATION:  
Randomization was performed with the help of computer generated randomization 
through numbers. The codes were issued in a sealed envelope. The group to which 
each patient was randomized to was conveyed to the operating team post-operatively. 
 
METHOD OF ALLOCATION CONCEALMENT:  
The allocation of patients was concealed pre-operatively. After the surgery, sealed 
envelopes with the randomization code were opened by the principal investigator and 
the randomization informed to the team. 
 
BLINDING AND MASKING:  
There was no masking or blinding performed during the study. 
 
SAMPLE SIZE CALCULATION: 
Sample size calculation was performed after going through other similar studies 
performed world-wide. For more accuracy, preliminary work was carried out by 
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assessing the retrospective data from the institution in the last 2 years, prior to starting 
the study. Although routine upper GI contrast study was being performed for all 
oesophageal anastomosis, some patients had been managed without a routine contrast 
study. Since this trial was proposed to assess the need for change in current practice, 
data on patients who had undergone an oesophageal anastomosis over the last 2 years, 
from General Surgery Unit 3 was analyzed based on available In-Patient records.  
The outcomes considered were: 
 Delay in starting normal diet. 
 Prolonged hospital stay. 
  17% and 30% was the prevalence in the two conditions. 
  The difference is considered as 10% and the average 
as 23 %. 77% is the complement of 23% i.e. 100-23 = 77. 
  Using a formula n= 4PQ/ D*D 
  Sample size = 75 in each arm. 
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DIAGRAMMATIC ALGORITHM OF THE STUDY: 
 
PATIENTS SELECTED FOR THE STUDY ACCORDING TO THE INCLUSION 
CRITERIA MENTIONED 
 
INFORMED CONSENT WAS OBTAINED 
 
OPERATION PERFORMED 
     RANDOMIZATION DONE 
  
                                     GROUP A    GROUP B 
 
 UPPER GI CONTRAST STUDY              NO ROUTINE UPPER GI  
 BETWEEN POD 5-7^                      CONTRAST STUDY ON POD 5-7*               
 
In both the groups, serial monitoring of clinical parameters like temperature, pulse 
rate, blood pressure, respiratory rate, signs of peritonitis or wound infection was 
carried out. The patients were also monitored for any major or minor morbidities that 
may occur.  
 
 
Complications were classified according to the Clavien-Dindo grading system as 
follows: 
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Grade I: Fever controlled with antipyretics only 
 Severe pain controlled with analgesics 
 Wound infection/discharge opened at 
bedside 
 Paralytic ileus 
Grade II: Wound infection/sepsis requiring 
antibiotic therapy 
 Chest infection managed with 
antibiotic therapy 
 Abdominal infection managed with 
antibiotic therapy 
 Post-operative blood transfusions 
 Total parenteral nutrition 
 Anastomotic leak managed with 
antibiotics only  
Grade III: Anastomotic leak with endoscopic 
intervention needed 
 Anastomotic leak with radiological 
intervention needed  
 Anastomotic leak with surgical 
intervention needed  
 Other complications requiring 
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endoscopic intervention / radiological 
intervention / surgical intervention 
Grade IIIA  If not requiring general anesthesia 
Grade IIIB If requiring general anesthesia 
Grade IVA Respiratory failure only or Renal 
failure  
Grade IVB Respiratory failure  
 Renal failure 
 Septic shock 
 Multi organ dysfunction 
Grade V: Death of the patient 
 
The duration of post-operative day was calculated in both groups. The day of 
operation was considered as post-operative day 1. The day of starting oral feeds, 
liquids followed by solids was recorded in both groups. The other data collected 
included demographic variables, risk factors like comorbid illness, nutritional status, 
preoperative chemotherapy or radiation therapy, stage of the disease etc. Intra-
operative factors like details of anaesthesia and blood transfusions, surgical details 
including technique, type and site of anastomosis etc. were noted. Post-operative 
details included the course in the hospital in terms of general wellbeing, clinical 
variables, laboratory parameters, duration of hospital stay etc. 
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For the patients randomized to Group A, who were slotted for a mandatory upper GI 
contrast study, a study was fixed according to the location of the anastomosis. The 
details of the randomization were conveyed to the operating team. In this group the 
day of starting liquids was determined by the patient’s clinical course and the day of 
starting a solid food was determined by a normal contrast study on POD 7-9. 
The patients who had systemic features to suggest a leak clinically, like fever or 
tachycardia were assessed diligently. Depending on the clinical picture and general 
condition of the patient a Contrast Enhanced Computed Tomogram was usually opted 
for by the operating team. The rationale being that, apart from confirming a leak, the 
extent of a peri-anastomotic collection and feasibility of radiological intervention for 
the same could be assessed. It had been decided at the start of the study to include 
these set of patients as part of an intention to treat analysis.  
In patient with features of Systemic Inflammatory response Syndrome, apart from 
considering an anastomotic leak, other causes like urinary tract infection, pneumonia 
etc. were also concurrently evaluated. 
After the upper GI contrast study was performed, the films were reviewed by the 
treating surgeons as well as officially reported by the radiologists.  
 
PROTOCOL VARIATIONS CONSIDERED:  
a. Interim analyses: If unable to complete target size, the data collected till then will be 
analyzed for significance. 
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b. For withdrawal of participants: The participants are allowed to withdraw at their 
discretion. If randomization has been done the numbers will be returned to the table. 
 
c. For premature stopping of trial: The reasons for the same will be analyzed and 
published. 
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6. RESULTS AND ANALYSIS 
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A randomized control trial was performed in the General Surgery Unit III, Christian 
Medical College, Vellore, from March 2014 to June 2015. In this study a total of 40 
patient were recruited. The data collected during the course of this study was analyzed 
with STATA 13.1 software. The statistical tests used were mainly the Independent 
sample t-test, Pearson χ2 statistic and Fisher’s exact test. A P-value of < 0.05 was 
considered statistically significant. 
Prior to starting the trial, a retrospective analysis was performed to assess the standard 
operating protocol employed after an oesophagectomy. Two years of data was 
analyzed. Of the 118 patients operated in this time period, 25% had been managed 
post operatively without undergoing a mandatory upper GI contrast study. Out of this 
25%, one-third had anastomotic leaks which were detected clinically or radiologically 
(CT scan being the most common modality), without a routine upper GI contrast study 
being performed. The remaining two-thirds had an uneventful post-operative period 
and were discharged on a normal diet. There was no morbidity or mortality in this 
group, where a routine contrast study was not performed. This data was also 
considered while calculating the sample size. Thus, the standard operating protocol 
existing in the unit meant that majority of patients underwent routine upper GI 
contrast studies after an oesophageal anastomosis – most commonly on the 7th post-
operative day. 
A total of 40 patients consented to be included into the study. They were randomized 
post-operatively into 2 groups wherein group A underwent a mandatory contrast study 
between the 7
th
 and 9
th
 post-operative days. The patients in group B were monitored 
strictly with clinical parameters to detect leaks early.  
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6.1 DEMOGRAPHIC PROFILE BETWEEN GROUPS: 
 GROUP A GROUP B 
AGE:     (Mean / SD)  48.1 (+/-14.29) 50.3 (+/- 12.3) 
SEX:     Males: 30 (75%) 
              Females:10(25%) 
20(90.91 %) 
2(9.09%) 
10(55.56%) 
8(44.44%) 
HISTOPATHOLOGY: 
1. Adenocarcinoma – 40% 
2. Squamous cell carcinoma – 
37.50% 
3. Corrosive strictures – 15% 
4. Leiomyoma – 2.50% 
5. GIST – 5% 
 
 
 
9(40.41%) 
7(31.82%) 
 
4(18.18%) 
1(4.55%) 
1(4.55%) 
 
7(38.89%) 
8(44.44%) 
 
2(11.11%) 
0(0%) 
1(5.56%) 
LOCATION OF 
TUMOR/STRICTURE 
 
1. Upper one-third of the 
oesophagus – 5% 
2. Middle one-third of the 
oesophagus – 37.50% 
3. Lower one-third of the 
oesophagus – 15% 
4. Gastro-esophageal junction – 
20%  
5. Fundus of the stomach – 
7.50% 
6. Body of the stomach – 15% 
 
 
 
 
0(0%) 
 
8(36.36%) 
 
3(13.64%) 
 
8(36.36%) 
 
1(4.55%) 
 
2(9.09%) 
 
 
 
2(11.11%) 
 
7(38.89%) 
 
3(16.67%) 
 
0(0%) 
 
2(11.11%) 
 
4(22.22%) 
OPERATIONS 
PERFORMED: 
1. Ivor-Lewis oesophagectomies 
– 17.50 % 
2. McKeown’s oesophagectomy 
– 40% 
3. Total gastrectomies – 30% 
4. Colon/gastric pull through – 
12.50%  
 
 
 
1(5.56%) 
 
9(50.00%) 
 
6(33.33%) 
2(11.11%) 
 
 
6(27.27%) 
 
7(31.82%) 
 
6(27.27%) 
3(13.64%) 
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ANASTOMOTIC LEAKS 
(Radiological and clinically 
detected) 
3 2 
ANASTOMOTIC LEAK 
DETECTED 
RADIOLOGICALLY 
1 0 
DAY OF STARTING 
LIQUIDS (Mean / SD) 
7.36(+/- 3.33) 6.52(+/-1.84) 
DAY OF STARTING 
SOLIDS (Mean / SD) 
9.72(+/-3.34) 7.58(+/-3.35) 
LENGTH OF HOSPITAL 
STAY IN DAYS 
(Mean / SD) 
13.63(+/- 3.78) 12.83(+/-3.71) 
MORTALITY 0 0 
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6.2 GENDER DISTRIBUTION: 
 
 
FIGURE 1 
Of the 40 patients recruited, there were 20 males in group A and 10 males in group B. 
There were 2 females in Group A and 8 females in group B. There was a definite male 
preponderance in the study population with 75% of the participants being male. This 
was in keeping with world literature that shows a predominant male population in 
oesophageal and gastric malignancies. 
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6.3 SMOKERS vs. NON SMOKERS: 
 
 
FIGURE 2 
 
There were 26 smokers and 14 non-smokers in Group A and B respectively. This 
constituted 65% and 35%. This difference was in parallel to the sex distribution with 
males forming the bulk of the smoking population. 
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6.4 ALCOHOL CONSUMERS Vs NON CONSUMERS: 
 
 
FIGURE 3 
 
Alcohol consumption among the study population was 82.50 % in group A and 
17.50% in group B with 33 consumers and 7 consumers respectively. This again 
reflected the sex distribution. 
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6.5 DIAGNOSIS AND INDICATIONS FOR OESOPHAGECTOMY: 
 
 
FIGURE 4 
The indications for an oesophagectomy included oesophageal malignancies, gastro-
oesophageal junction malignancies, proximal gastric cancer and corrosive 
oesophageal strictures. The histopathological variations among lesions is distributed 
as follows: 
1) Adenocarcinoma – 40% 
2) Squamous cell carcinoma – 37.50% 
3) Corrosive strictures – 15% 
4) Leiomyoma – 2.50% 
5) GIST – 5% 
 
 
  
 
 
 
66 
6.6 LOCATION OF THE LESION: 
 
 
FIGURE 5 
 
1) Upper one-third of the oesophagus – 5% 
2) Middle one-third of the oesophagus – 37.50% 
3) Lower one-third of the oesophagus – 15% 
4) Gastro-esophageal junction – 20%  
5) Fundus of the stomach – 7.50% 
6) Body of the stomach – 15% 
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6.7 OPERATIONS PERFORMED: 
 
  
FIGURE 6 
 
The surgical procedures performed included Ivor-Lewis oesophagectomies, 
McKeown’s oesophagectomies, total gastrectomies and bypass procedures for 
strictures. 
The incidence of procedures was: 
1) Ivor-Lewis oesophagectomies – 17.50 % 
2) McKeown’s oesophagectomy – 40% 
3) Total gastrectomies – 30% 
4) Colon/gastric pull through – 12.50%  
The rates of these procedures among the study population reflected the trend in 
location of tumors and strictures.  
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6.8 ANASTOMOTIC LEAKS: 
 
 
FIGURE 7 
 
The overall leak rate among the study population – detected clinically or by imaging 
was 12.50%. 3 patients in Group A and 2 in Group B had an anastomotic leak. 
 
The leak rates between groups were comparable. However in group A out of the 3 
leaks only 1 leak was detected by the routine barium swallow. This was a total 
gastrectomy with an intra-abdominal leak. Both the cervical anastomotic leaks were 
missed and were detected on test feeds.  
 
Out of the 2 cervical leaks in Group B, both were clinically detected. 
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6.9 SITE OF ANASTOMOSIS AND INCIDENCE OF ASSOCIATED LEAKS: 
 
 
FIGURE 8 
 
There were a total of 5 leaks in the study population (n = 5/40; 12.50%). There were 4 
cervical anastomotic leaks, no intra-thoracic leaks and 1 intra-abdominal leak. The 
higher incidence of cervical leaks was probably an outcome of the increased incidence 
of McKeown’s oesophagectomies in the study population. However, on analyzing 
these numbers with the Chi square test, a P value of 0.365 was derived, showing that 
the site of anastomosis did not confer an added risk. Thus, the apparently high 
incidence of cervical anastomotic leaks was not statistically significant.
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6.10 ANASTOMOTIC TECHNIQUE AND INCIDENCE OF LEAKS: 
 
 
FIGURE 9 
 
The two commonly favored anastomotic techniques were hand sewn 
interrupted sutures and mechanical staples. The preference was as follows: 
1. Hand sewn interrupted (n = 35/40; 87.50%) 
2. Staples (n = 5/40; 12.50%) 
The leak rates between the 2 techniques were analyzed with Chi 
square test. The P value was 0.738 which was not statistically significant. 
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6 SENSITIVITY AND SPECIFICITY OF UPPER GI CONTRAST STUDIES: 
 
SENSITIVITY 13.60% 
SPECIFICITY 88.60% 
POSITIVE 
PREDICTIVE VALUE 
60.00% 
NEGATIVE 
PREDICTIVE VALUE 
45.70% 
 
 
The sensitivity and specificity of upper GI contrast studies were 
assessed in comparison to clinically or CECT detected leaks. It was found that the test 
had a significantly low sensitivity but fairly good specificity. In routine practice it was 
more helpful to rule out a leak than to detect anastomotic leaks. 
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6.12 DAY OF STARTING LIQUIDS ORALLY: 
 
 
FIGURE 10 
 
Out of the 40 patients recruited, 1 could not be started on oral feeds 
due to persistent aspiration. On an average the patients in Group A started taking 
liquids on the 7
th
 post-operative day and those in Group B started on the 6
th
 post-
operative day. There was no statistical difference in this outcome between the groups 
(P value – 0.359). 
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6.13 DAY OF STARTING SOLIDS: 
 
 
FIGURE 11 
As part of the study protocol and in keeping with existing practice, 
the patients in Group A started taking solid diet after a normal upper GI contrast 
study. Hence, on an average, members in Group A were started on solids on the 9
th
 
post-operative day while those who were in Group B started taking a normal diet on 
the 7
th
 post-operative day. Chi square test produced a P value of 0.0553 which 
revealed a probable statistically significant difference in between groups. 
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6.14 LENGTH OF HOSPITAL STAY: 
 
 
FIGURE 12 
 
The length of hospital stay after the operation differed by a day 
between the two groups. On an average the patients in group A stayed a total of 13.6 
days while those in Group B stayed for 12.8 days. However, this difference was not 
statistically significant (P value – 0.505).  
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6.15 COMPLICATION RATES: 
 
 
FIGURE 13 
The complications occurring among patients in both groups were 
classified according to the Clavien-Dindo grading system. Out of the 40 patients, who 
were part of the study, 15(38.46%) had an uneventful post-operative period. 
9(23.08%) had Grade 1, 12(30.77%) had Grade 2 and 2(5.13%) had Grade 3 
complications. Only 1(2.56%) patient had a Grade 4 complication. There were no 
mortalities in the study population.  Statistical analysis of the complication rates did 
not reveal any significant change in the incidence of complications between groups. (P 
value – 0.896) 
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6.16 COMPARISON OF RE-ADMISSION, RE-INTUBATION AND RE-
OPERATION RATES: 
 
FIGURE 14 
In Group A, 1 patient was re-admitted for conservative management 
of a wound dehiscence, which occurred following discharge. He had had a normal 
contrast study. In Group B, 2 patients were re-admitted. 1 was detected to have deep 
vein thrombosis following a central venous access catheter insertion and another was 
admitted for urinary tract infection. In Group A 2 patients were re-intubated. One for 
unexplained deterioration with hypoxia, hypotension and tachycardia and the second 
for an infected ascites, requiring peritoneal lavage. There were no patients who 
required re-intubation or re-operation in Group B. Statistically, the P values for 
comparing re-admission, re-intubation and re-operation rates were 0.433, 0.492 and 
>0.99. 
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6.17 SYNOPSIS OF OUTCOMES AND STATISTICAL SIGNIFICANCE: 
 
 
VARIABLE  
V
VALUES 
 
SIGNIFICANT OR NOT 
Leaks according to the 
technique of 
anastomosis 
0
.738 
Not significant 
Leaks according to the 
location of the 
anastomosis 
0
.549 
Not significant 
Difference in date of 
starting liquids 
0
.359 
Not significant 
Difference in date of 
starting solids 
0
.055 
Probably significant 
Difference in length of 
hospital stay 
0
.505 
Not significant 
Difference in 
complication rates 
0
.896 
Not significant 
Difference in re-
admission rates 
0
.433 
Not significant 
Difference in re-
intubation rates 
0
.492 
Not significant 
Difference in re-
operation rates 
>0.99 Not significant 
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7. DISCUSSION 
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7.1 CONSORT CHART: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assessed for eligibility 
 (n =45) 
Not consented (n=5) 
 
Randomized (n =40) 
Allocated to Group A (n=22) 
Underwent routine upper GI contrast 
study (n = 17) 
Routine upper GI contrast study was 
not done (n =5) 
1 was in ICU due to pleural effusion 
1 had peritonitis due to infected 
ascites and underwent re-
laparotomy. 
3 were cancelled by the treating 
clinician as patients were clinically 
well. 
 
 
A
ll
o
ca
ti
o
n
 
En
ro
llm
en
t 
Allocated to Group B 
(n =18) 
Routine upper GI contrast study 
was not done (n =18) 
Other radiological imaging 
(CECT) done (n =2)  
1 patient had fever and 
tachycardia due to UTI 
1 patient had upper limb acute 
DVT. 
F
o
ll
o
w
 u
p
 2 cervical leaks – missed by the 
routine upper GI contrast study. 
1 abdominal leak – detected by 
the routine upper GI contrast 
study. 
 
2 cervical leaks – detected 
only by clinical methods 
Delay in starting solids by 1 day 
(P value – 0.055) 
No increase in re-admission or 
re-operation rates (P value – 
0.433 and >0.99) 
No increase in complication 
rates (P value - 0.896) 
A
n
a
ly
si
s 
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Five patients in Group A failed to undergo the scheduled upper GI contrast study. One 
patient had fever, tachycardia and peritonitis. He underwent a CECT of the abdomen, 
for a suspected leak which showed an infected ascites. He underwent a laparotomy 
and peritoneal lavage. Following the lavage, he improved and was discharged well. 
The 2
nd
 patient failed to undergo the scheduled study because he had persistent, 
unexplained tachycardia post operatively. On further evaluation he was found to have 
developed pleural effusion which was the reason for the tachycardia.  
In group A, the other 3 patients failed to undergo the scheduled routine upper GI 
contrast study since the operating team felt it was unwarranted. 
 One patient in Group A had unexplained hypotension and desaturation on the 10
th
 
post-operative day for which he was re-intubated and started on inotropic supports. He 
had undergone a routine barium swallow on the 7
th
 post-operative day which was 
normal. However, in view of his deterioration, a missed anastomotic leak was 
suspected and he was subjected to a Contrast Enhanced Computed Tomogram. The 
study failed to yield any useful results due to the residual barium coating the 
oesophagus which caused intense scatter. This has already been quoted as a drawback 
of doing routine upper GI contrast studies. The patient was offered supportive care 
and recovered fully after 72 hours and was subsequently discharged on a normal diet 
orally. 
17 patients were randomized to Group B and hence did not undergo a routine upper 
GI contrast study. In this group 2 patients had anastomotic leaks at the cervical region 
which were picked up clinically and managed conservatively. Two other patients 
underwent Contrast Enhanced Computed Tomograms for suspected anastomotic leaks 
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when they developed fever and tachycardia. One patient was later proven to have 
urinary tract infection and the second patient had acute Deep Vein Thrombosis of the 
upper limb secondary to a central venous access catheter placement. She underwent a 
re-operation for the same (Clavien – Dindo Grade IV complication).  
The non-anastomotic complications among the group members included pneumonia, 
urinary tract infections, acute cholecystitis etc.  
Five patients out of 40 had anastomotic leaks which were detected either during the 
upper GI contrast study or clinically. There were 4 cervical anastomotic leaks (2 in 
Group A and 2 in Group B), 1 intra-abdominal anastomotic leak and no intra-thoracic 
anastomotic leaks. All the cervical anastomotic leaks in Group A were missed by the 
contrast study but were detected clinically. There were no added adverse effects 
secondary to the cervical leaks. The patient with an intra-abdominal leak was 
suspected to have a leak, based on the high, bilious drain output, prior to the study. 
This was confirmed by the upper GI contrast study which revealed extravasation at the 
oesophago-jejunal anastomosis (Radiograph in Annexure 1). She was managed 
conservatively and was discharged well. There were 2 anastomotic leaks in group B 
and both were cervical leaks which were picked up clinically without the need for a 
contrast study.  
 
 
7.2 COMPARISON OF STUDY DATA WITH WORLD LITERATURE: 
 The anastomotic leak rate in this study was 12.50%. The literature available on the 
incidence of anastomotic leaks spans a wide range. Urchel et al reported the incidence 
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of anastomotic leak to be 17% in their series(48) and Bardini et al reported it to be as 
high as 53%(37). This wide disparity and range of incidence in anastomotic leaks is 
due to a lack of consensus for the definition of an anastomotic leaks. Most papers 
which we reviewed, relied on contrast studies to define leaks. The drawback to this is 
that most centers around the world now rely on clinical parameters to detect leaks 
since clinically occult leaks are usually of no grave consequence.(37) The average 
leak rate was around 15 – 20%(79) and our leak rates were within recommended 
norms. 
Barium sulfate is an inorganic compound. It is a white crystalline solid that is odorless 
and insoluble in water. It is used as a radiocontrast agent for imaging the GI tract. 
Although barium is a heavy metal, and its water-soluble compounds are often highly 
toxic, the low solubility of barium sulfate protects the patient from absorbing harmful 
amounts of the metal. Barium sulfate is also readily removed from the body. However, 
while performing an upper GI contrast study to look for anastomotic leaks after an 
oesophagectomy, the risk of aspiration needs to be considered. Barium was less 
harmful to the mediastinum and lungs than aqueous contrast media if aspirated (69). 
In patients with an intra-abdominal anastomosis, barium sulfate can cause chemical 
peritonitis. Hence, the alternative in these patients is Gastrografin (Diatrizoate 
Meglumine) which is an iodinated radiocontrast agent. Gastrografin is contraindicated 
in patients at risk of aspiration as it can result in pulmonary edema due to its 
hypertonic nature.  
In this study patients with cervical and thoracic anastomosis underwent thin barium 
studies while those with abdominal anastomosis underwent a Gastrografin study. 
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In Group A, where a routine contrast study was performed 2 patients had 
complications due to the study. 1 patient developed profound cough and the study was 
prolonged. Another patient has aspiration into the trachea-bronchial tree, though he 
recovered uneventfully following the same (Radiograph in Annexure 2). There were 
no major adverse effects. Incidentally, these patients expressed a strong dislike to the 
taste and texture of the solution and stated it to be an unpleasant experience. The 
majority of the patients who had refused to participate in the study had undergone a 
pre-operative barium swallow and hence cited the unpleasant taste to be a reason for 
refusing consent. 
As part of the study, the upper GI contrast study for these patients was funded by the 
Institution. Otherwise an additional cost of Rs.1250 would have been borne by the 
patients. Thereby avoiding a routine contrast study will save the above mentioned cost 
to the patient. 
There were 2 cervical anastomotic leaks in patients randomized to Group B. They 
were both detected clinically and managed conservatively. Thus, no anastomosis 
related complications were missed in Group B. Two other patients were suspected to 
have anastomotic leaks due to fever and tachycardia, but were diagnosed to have UTI 
and DVT respectively. They were subjected to CECT scans as per the study protocol. 
 The sensitivity and specificity of upper GI contrast studies in our series was 13.60% 
and 88.60% respectively with a confidence interval of 95%. Around the world, studies 
by different authors have claimed sensitivity ranging from 47% to 85%(68) and 
specificity ranging from 73 – 97% (68).  
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Tirnaksiz et al(2) and Tonouchi et al(65) assessed the usefulness of Gastrografin / 
Barium swallow as a screening procedure for anastomotic leaks in 2005 and 2007 
respectively. Tirnaksiz et al found the test to have a sensitivity of 40.4% and 
specificity of 97%. As per their data the false positive rate was 5.2% and false 
negative rate was 59.5%. The outcome of both trials was to use Gastrografin or 
barium swallows as a screening test following total gastrectomy with great caution, I 
view of the low sensitivity of these modalities. This data is compared with our study 
below.  
 CMC STUDY TIRNAKSIZ ET AL 
SENSITIVITY 13.60%  40.4 % 
SPECIFICITY 88.60 % 97.0% 
POSITIVE 
PREDICTIVE 
VALUE 
60.00% 43.5 % 
NEGATIVE 
PREDICTIVE 
VALUE 
45.70 % 94.1% 
 
The day of starting oral feeds following an oesophageal anastomosis has significance 
since gastric distension following the operation and poor anastomotic wound maturity 
have been cited as reasons for late leaks(after 7 days).(37)(48) 
However, recent studies by Cooke et al have shown that by the 7
th
 – 10th post-
operative day most patients are well enough to take a solid diet and be discharged. The 
drawbacks of delay in start of feeds can add to prolonged hospital stay and the 
accompanying morbidities.(54) Our study showed a statistically significant delay of 1 
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day in starting solid diet in patients who were subjected to a routine upper GI contrast 
study. 
 Goel et al, in 1995, questioned the practice of doing a routine Gastrografin swallow to 
assess cervical oesophageal anastomotic integrity. They performed a prospective trial 
among 25 patients, where test feeds with water detected 3 anastomotic leaks including 
1 missed by the subsequent Gastrografin swallow. They proposed test feeding with 
graded feeds starting from water to be a better option, than routine upper GI contrast 
studies with low sensitivity(64). This was further emphasized by Boone et al, in 2008, 
who advocated that the routine practice of doing a Gastrografin swallow be abandoned 
in favor of water test feeds. (81) In our study this was true for 4 out of 4 leaks where 
there was extravasation of test feeds from the neck. Out of these 2 patients had a false 
negative Barium swallow oeosphagogram.  
Griffin and Lamb et al in 2001, studied the efficacy between upper GI contrast study 
and flexible upper GI endoscopy in detecting mediastinal leaks. During the course of 
their study 6 patients with normal contrast studies developed endoscopy proven 
leaks.(6) In our study population there were no intra-thoracic anastomotic leaks 
detected clinically or on radiological imaging. Another study was performed by 
Griffin et al in 2004 to assess usefulness of barium swallow to assess an oesophago 
jejunal anastomosis following a total gastrectomy. They published that 2 out of 8 leaks 
proven by endoscopy were missed by the barium swallow.(6)  
There were no studies that compared the length of hospital stay between groups. 
Maxime Nguyen et al in 2014, carried out a prospective trial to assess the usefulness 
of upper GI barium swallows in detecting occult anastomotic leaks.(7) This study was 
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carried out among 221 patients and it was concluded with the recommendation that a 
contrast oesphagogram was not an ideal screening modality to detect anastomotic 
leaks. They further advised the use of this test in a targeted fashion for patients with 
suspected leaks and systemic features of the same.  
The latest work in this field has been a Best Evidence Topic paper published in 2015 
by Christopher M. Jones et al. They reviewed the articles by Cooke, Boone, Tirnaksiz 
and Goel et al. They said that the pros and cons of doing a routine upper GI contrast 
study after an oesophageal anastomosis precluded its use as a routine screening 
test.(66) They also commented that there were no adverse outcomes seen in those not 
undergoing the study. In our study the comparison of complications between groups 
did not show a statistical difference. 
 This study reiterates the fact that doing a routine upper GI study confers no added 
clinical benefit. Instead, it delayed the initiation of solids by one day. Furthermore, 
there was no increase in complication rates by foregoing the study in clinically well 
patients. 
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8. LIMITATIONS OF THE 
STUDY 
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 The calculated sample size was not attained. Hence, the results from the study should 
be applied to the general population with caution and judiciousness.  
 
 There were more cervical anastomosis in the contrast group as per the randomization. 
There were also more McKeown’s oesophagectomies reformed. This caused an 
unequal distribution, which again could be a fallacy while interpreting the outcomes. 
 
 There were no intra-thoracic anastomotic leaks in the study population. Hence, the 
importance of a routine upper GI contrast study in detecting such leaks could not be 
assessed. 
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9. CONCLUSIONS 
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 There was no increase in rate of morbidity or mortality in patients who did not 
routinely have a contrast swallow prior to initiation of feeds (Group B).  
 Routine upper GI contrast studies after an oesophageal anastomosis did not 
offer any additional clinical benefit. In fact, two patients had aspiration of the contrast 
medium although there were no untoward consequences as a result of this.  
 The use of an upper GI contrast study has a low sensitivity (13.60%) and hence 
it may not be of value as a screening test to detect a post-operative leak. 
 The negative predictive value of this study is 45.70%. Hence, relying on this 
test to rule out a leak may give a false sense of security and may lead to missed leaks. 
 Scheduling an upper GI contrast study on the 7th post-operative day delayed the 
initiation of solid feeds by a day, adding to the length of hospital stay and therefore 
the cost incurred by the patient.  
 In this study, the 2 patients with a neck anastomotic leak were not picked up by 
the contrast study. This therefore proves that a contrast study is not of much value in 
cervical oesophageal anastomosis. 
 One patient had an abdominal anastomotic leak confirmed on contrast study. 
But this leak would have been clinically picked up even without a study. Therefore 
this underlines the fact that selective use of contrast study is more appropriate.  
 Hence, the routine use of contrast study to rule out a post-operative 
oesophageal anastomotic leak can probably be abandoned. The need for an 
appropriate study can be made by the treating clinician, based on the level of clinical 
suspicion and the local expertise available.  
  
 
 
 
91 
 
 
 
 
 
 
 
 
 
 
 
 
10. BIBLIOGRAPHY 
 
 
 
 
 
 
 
 
 
  
 
 
 
92 
1. Oestmann J, Langenbruch K, Meyer HJ, Gerlings H. [Detection of insufficiencies 
of enteroenteral anastomoses following gastrectomies by studies with water soluble 
contrast media--time and study quality]. Rontgen-Blatter Z Rontgen-Tech Med-Wiss 
Photogr. 1985;38(11):356–8.  
2.  Tirnaksiz MB, Deschamps C, Allen MS, Johnson DC, Pairolero PC. 
Effectiveness of screening aqueous contrast swallow in detecting clinically significant 
anastomotic leaks after esophagectomy. Eur Surg Res Eur Chir Forsch Rech Chir Eur. 
2005 Apr;37(2):123–8.  
3.  Boone J, Rinkes IB, Van Leeuwen M, Van Hillegersberg R. Diagnostic value of 
routine aqueous contrast swallow examination after oesophagectomy for detecting 
leakage of the cervical oesophagogastric anastomosis. ANZ J Surg. 2008;78(9):784–
90.  
4.  Solomon DG, Sasaki CT, Salem RR. An evaluation of the routine use of contrast 
radiography as a screening test for cervical anastomotic integrity after esophagectomy. 
Am J Surg. 2012;203(4):467–71.  
5.  Honing J, Pultrum BB, van der Jagt EJ, Groen H, Plukker JTM. Routine or on demand 
radiological contrast examination in the diagnosis of anastomotic leakage after 
esophagectomy. J Surg Oncol. 2009 Dec 15;100(8):699–702.  
6.  Griffin SM, Lamb PJ, Dresner SM, Richardson DL, Hayes N. Diagnosis and 
management of a mediastinal leak following radical oesophagectomy. Br J Surg. 
2001;88(10):1346–51.  
7.  Cools-Lartigue J, Andalib A, Abo-Alsaud A, Gowing S, Nguyen M, Mulder D, et al. 
Routine Contrast Esophagram has Minimal Impact on the Postoperative Management 
of Patients Undergoing Esophagectomy for Esophageal Cancer. Ann Surg Oncol. 
2014 Mar 28;21(8):2573–9.  
8.  Dikshit RP, Mathur G, Mhatre S, Yeole BB. Epidemiological review of gastric cancer 
in India. Indian J Med Paediatr Oncol Off J Indian Soc Med Paediatr Oncol. 
2011;32(1):3–11.  
9.  Wheeler JB, Reed CE. Epidemiology of Esophageal Cancer. Surg Clin North Am. 
2012 Oct;92(5):1077–87.  
10.  Gopala Krishnappa BR, Vijay CR, Ramesh C, Bapsy PP, Kumar MU, Vijayakumar 
M, et al. Trends in oesophagus and Stomach cancer incidence in Bangalore, India. 
Gulf J Oncolog. 2013 Jan;1(13):42–50.  
11.  Chibishev A, Pereska Z, Chibisheva V, Simonovska N. Corrosive Poisonings in 
Adults. Mater Socio-Medica. 2012;24(2):125–30.  
12.  Znaor A, Brennan P, Gajalakshmi V, Mathew A, Shanta V, Varghese C, et al. 
Independent and combined effects of tobacco smoking, chewing and alcohol drinking 
on the risk of oral, pharyngeal and esophageal cancers in Indian men. Int J Cancer. 
2003 Jul 10;105(5):681–6.  
13.  Prabhu A, Obi KO, Rubenstein JH. The Synergistic Effects of Alcohol and Tobacco 
Consumption on the Risk of Esophageal Squamous Cell Carcinoma: A Meta-
Analysis. Am J Gastroenterol. 2014 Jun;109(6):822–7.  
14.  DeVita, Hellman, and Rosenberg’s Cancer: Principles & Practice of Oncology. Tenth 
edition. Philadelphia: LWW; 2014. 2280 p.  
  
 
 
 
93 
15.  DeVita, Hellman, and Rosenberg’s Cancer: Principles & Practice of Oncology 
(Cancer Principles and Practice of Oncology) 
 16.  Brandwein-Gensler M, Smith RV. Prognostic Indicators in Head and Neck Oncology 
Including the New 7th Edition of the AJCC Staging System. Head Neck Pathol. 2010 
Feb 6;4(1):53–61.  
17.  Kong S-H, Park DJ, Lee H-J, Jung HC, Lee KU, Choe KJ, et al. Clinicopathologic 
features of asymptomatic gastric adenocarcinoma patients in Korea. Jpn J Clin Oncol. 
2004 Jan;34(1):1–7.  
18.   [cited 2015 Aug 30]. Available from: http://scholar.google.com.sci-
hub.org/scholar_url?url=http%3A%2F%2Fonlinelibrary.wiley.com.sci-
hub.org%2Fdoi%2F10.1111%2Fdote.12171%2Fpdf&hl=en&sa=T&ct=res&cd=0&ei
=dwfjVfjVOoK8jAHaq6_ABw&scisig=AAGBfm0cAfKd3f8plUa3fSO7mhLvFhmi1
g&nossl=1&ws=1366x634 
19.  Kakegawa T, Fujita H. A history of esophageal surgery in the twentieth century. Gen 
Thorac Cardiovasc Surg. 2009 Feb;57(2):55–63.  
20.  Franklin RH. Ivor Lewis Lecture, 1975. The advancing frontiers of oesophageal 
surgery. Ann R Coll Surg Engl. 1977 Jul;59(4):284–7.  
21.  Orringer MB, Sloan H. Esophagectomy without thoracotomy. J Thorac Cardiovasc 
Surg. 1978 Nov;76(5):643–54.  
22.  Surgical treatment of caustic esophageal strictures in adults - International Journal of 
Surgery [Internet]. [cited 2015 Aug 31]. Available from: http://www.journal-
surgery.net/article/S1743-9191(12)00857-6/fulltext 
23.  PII: S1010-7940(01)00747-3 - 1.full.pdf [Internet]. [cited 2015 Sep 2]. Available 
from: http://ejcts.oxfordjournals.org/content/20/1/1.full.pdf 
24.  Csikos M, Horváth Ö, Petri A, Petri I, Imre J. Late malignant transformation of 
chronic corrosive oesophageal strictures. Langenbecks Arch Für Chir. 1985 
Dec;365(4):231–8.  
25.  Corrosive injuries of the oesophagus and stomach: experience in management at a 
regional paediatric centre. [Internet]. [cited 2015 Sep 2]. Available from: 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2502539/ 
26.  Javed A, Pal S, Dash NR, Sahni P, Chattopadhyay TK. Outcome following surgical 
management of corrosive strictures of the esophagus. Ann Surg. 2011 Jul;254(1):62–
6.  
27.  Thompson SK, Chang EY, Jobe BA. Clinical review: Healing in gastrointestinal 
anastomoses, part I. Microsurgery. 2006;26(3):131–6.  
28.  Thornton FJ, Barbul A. Healing in the gastrointestinal tract. Surg Clin North Am. 
1997 Jun;77(3):549–73.  
29.  Low DE, Alderson D, Cecconello I, Chang AC, Darling GE, DʼJourno XB, et al. 
International Consensus on Standardization of Data Collection for Complications 
Associated With Esophagectomy: Esophagectomy Complications Consensus Group 
(ECCG). Ann Surg. 2015 Aug;262(2):286–94.  
30.  Lerut T, Coosemans W, Decker G, De Leyn P, Nafteux P, van Raemdonck D. 
Anastomotic complications after esophagectomy. Dig Surg. 2002;19(2):92–8.  
  
 
 
 
94 
31.  Atkins BZ, Shah AS, Hutcheson KA, Mangum JH, Pappas TN, Harpole Jr DH, et al. 
Reducing Hospital Morbidity and Mortality Following Esophagectomy. Ann Thorac 
Surg. 2004 Oct;78(4):1170–6.  
32.  Urschel JD. Esophagogastrostomy anastomotic leaks complicating esophagectomy: A 
review. Am J Surg. 1995 Jun;169(6):634–40.  
33.  Lee Y, Fujita H, Yamana H, Kakegawa T. Factors affecting leakage following 
esophageal anastomosis. Surg Today. 1994;24(1):24–9.  
34.  Hajj II El, Imperiale TF, Rex DK, Ballard D, Kesler KA, Birdas TJ, et al. Treatment 
of esophageal leaks, fistulae, and perforations with temporary stents: evaluation of 
efficacy, adverse events, and factors associated with successful outcomes. Gastrointest 
Endosc. 2014 Apr;79(4):589–98.  
35.  Peel AL, Taylor EW. Proposed definitions for the audit of postoperative infection: a 
discussion paper. Surgical Infection Study Group. Ann R Coll Surg Engl. 1991 
Nov;73(6):385–8.  
36.  Aminian A, Panahi N, Mirsharifi R, Karimian F, Meysamie A, Khorgami Z, et al. 
Predictors and outcome of cervical anastomotic leakage after esophageal cancer 
surgery. J Cancer Res Ther. 2011 Dec;7(4):448–53.  
37.  Lerut T, Coosemans W, Decker G, De Leyn P, Nafteux P, Van Raemdonck D. 
Anastomotic Complications after Esophagectomy. Dig Surg. 2002;19(2):92–8.  
38.  Vascular anatomy of the gastric tube used for esophageal reconstruction [Internet]. 
[cited 2015 Sep 6]. Available from: 
http://www.sciencedirect.com/science/article/pii/000349759290077H 
39.  Delayed postoperative emptying after esophageal resection is dependent on the size of 
the... - Abstract - Europe PubMed Central [Internet]. [cited 2015 Sep 6]. Available 
from: http://europepmc.org/abstract/med/7719551 
40.  Oesophagectomy by a trans hiatal approach or thoracotomy: A prospective 
randomized trial - Goldminc - 2005 - British Journal of Surgery - Wiley Online 
Library [Internet]. [cited 2015 Sep 6]. Available from: 
http://onlinelibrary.wiley.com/doi/10.1002/bjs.1800800335/pdf 
41.  Chu K-M, Law SYK, Fok M, Wong J. A prospective randomized comparison of trans 
hiatal and trans thoracic resection for lower-third esophageal carcinoma. Am J Surg. 
1997 Sep;174(3):320–4.  
42.  Trans hiatal esophagectomy without thoracotomy for carcinoma of the thoracic 
esophagus. [Internet]. [cited 2015 Aug 31]. Available from: 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1250471/ 
43.  Halsted WS. CIRCULAR SUTURE OF THE INTESTINE–AN EXPERIMENTAL 
STUDY: Am J Med Sci. 1887 Oct;188:436–60.  
44.  Czerny V v. Zur Darmresektion. Berl Klin Wschr. 1880;17:637.  
45.  Single layer versus double layer suture anastomosis of the gastrointestinal tract - 
CD005477.pdf [Internet]. [cited 2015 Sep 6]. Available from: http://www.update-
software.com/BCP/WileyPDF/EN/CD005477.pdf 
46.  Liu Q-X, Qiu Y, Deng X-F, Min J-X, Dai J-G. Comparison of outcomes following 
end-to-end hand-sewn and mechanical oesophagogastric anastomosis after 
oesophagectomy for carcinoma: a prospective randomized controlled trial. Eur J 
Cardiothorac Surg. 2014 Dec 4;ezu457.  
  
 
 
 
95 
47.  Wang Q, He X-R, Shi C-H, Tian J-H, Jiang L, He S-L, et al. Hand-Sewn Versus 
Stapled Esophagogastric Anastomosis in the Neck: A Systematic Review and Meta-
analysis of Randomized Controlled Trials. Indian J Surg. 2015 Apr;77(2):133–40.  
48.  Urschel JD. Esophagogastrostomy anastomotic leaks complicating esophagectomy: a 
review. Am J Surg. 1995 Jun;169(6):634–40.  
49.  Urschel JD. Esophagogastrostomy anastomotic leaks complicating esophagectomy: a 
review. Am J Surg. 1995 Jun;169(6):634–40. 
50.  Law S, Arcilla C, Chu K, Wong J. The significance of histologically infiltrated 
resection margin after esophagectomy for esophageal cancer. Am J Surg. 1998 
Sep;176(3):286–90.  
51.  Wolfárd A, Paszt A, Szentpáli K, Hideghéthy K, Uhercsák G, Németh I, et al. 
Efficacy and drawbacks of neoadjuvant chemoradiotherapy in squamous cell 
carcinoma of the thoracic esophagus. Hepatogastroenterology. 2011 
Aug;58(109):1214–9.  
52.  Gronnier C, Tréchot B, Duhamel A, Mabrut J-Y, Bail J-P, Carrere N, et al. Impact of 
neoadjuvant chemoradiotherapy on postoperative outcomes after esophageal cancer 
resection: results of a European multicenter study. Ann Surg. 2014 Nov;260(5):764–
70; discussion 770–1.  
53.  Hamai Y, Hihara J, Taomoto J, Yamakita I, Ibuki Y, Okada M. Effects of neoadjuvant 
chemoradiotherapy on postoperative morbidity and mortality associated with 
esophageal cancer. Dis Esophagus Off J Int Soc Dis Esophagus ISDE. 2015 
Jun;28(4):358–64.  
54.  Cooke DT, Lin GC, Lau CL, Zhang L, Si M-S, Lee J, et al. Analysis of Cervical 
Esophagogastric Anastomotic Leaks After Trans hiatal Esophagectomy: Risk Factors, 
Presentation, and Detection. Ann Thorac Surg. 2009 Jul;88(1):177–85.  
55.  Crestanello JA, Deschamps C, Cassivi SD, Nichols III FC, Allen MS, Schleck C, et al. 
Selective management of intrathoracic anastomotic leak after esophagectomy. J 
Thorac Cardiovasc Surg. 2005 Feb;129(2):254–60.  
56.  Alanezi K, Urschel JD. Mortality secondary to esophageal anastomotic leak. Ann 
Thorac Cardiovasc Surg. 2004;10(2):71–5.  
57.  Cannon WB. The movements of the intestines studied by means of the roentgen rays. 
1902.  
58.  Bliss AA. Foreign body (iron staple) in the oesophagus located by means of roentgen 
rays. Intern Med Mag. 1874;6:83.  
59.  Adolph W, Taplin GV. Use of Micropulverized Barium Sulfate in X-Ray Diagnosis. 
Radiology. 1950 Jun 1;54(6):878–83.  
60.  Vessal K, Montali RJ, Larson SM, Chaffee V, James AE. Evaluation of barium and 
gastrografin as contrast media for the diagnosis of esophageal ruptures or perforations. 
Am J Roentgenol. 1975 Feb 1;123(2):307–19.  
61.  Dodds WJ, Stewart ET, Vlymen WJ. Appropriate contrast media for evaluation of 
esophageal disruption. Radiology. 1982;144(2):439–41.  
62.  Foley MJ, Ghahremani GG, Rogers LF. Reappraisal of contrast media used to detect 
upper gastrointestinal perforations: comparison of ionic water-soluble media with 
barium sulfate. Radiology. 1982;144(2):231–7.  
  
 
 
 
96 
63.  Agha FP, Orringer MB, Amendola MA. Gastric interposition following trans hiatal 
esophagectomy: Radiographic evaluation. Gastrointest Radiol. 1985 Dec;10(1):17–24.  
64.  Goel AK, Sinha S, Chattopadhyay TK. Role of gastrografin study in the assessment of 
anastomotic leaks from cervical oesophagogastric anastomosis. Aust N Z J Surg. 1995 
Jan;65(1):8–10.  
65.  Tonouchi H, Mohri Y, Tanaka K, Ohi M, Kobayashi M, Yamakado K, et al. 
Diagnostic Sensitivity of Contrast Swallow for Leakage after Gastric Resection. 
World J Surg. 2006 Dec 8;31(1):128–31.  
66.  Jones CM, Heah R, Clarke B, Griffiths EA. Should routine radiological assessment of 
anastomotic integrity be performed after oesophagectomy with cervical anastomosis? 
Best evidence topic (BET). Int J Surg Lond Engl. 2015 Mar;15:90–4.  
67.  Heiken JP, Balfe DM, Roper CL. CT evaluation after esophagogastrectomy. Am J 
Roentgenol. 1984;143(3):555–60.  
68.  Hogan BA, Winter D, Broe D, Broe P, Lee MJ. Prospective trial comparing contrast 
swallow, computed tomography and endoscopy to identify anastomotic leak following 
oesophagogastric surgery. Surg Endosc. 2007 Dec 11;22(3):767–71.  
69.  Lantos JE, Levine MS, Rubesin SE, Lau CT, Torigian DA. Comparison Between 
Esophagography and Chest Computed Tomography for Evaluation of Leaks After 
Esophagectomy and Gastric Pull-through: J Thorac Imaging. 2013 Mar;28(2):121–8.  
70.  Strauss C, Mal F, Perniceni T, Bouzar N, Lenoir S, Gayet B, et al. Computed 
tomography versus water-soluble contrast swallow in the detection of intrathoracic 
anastomotic leak complicating esophagogastrectomy (Ivor Lewis): a prospective study 
in 97 patients. Ann Surg. 2010 Apr;251(4):647–51.  
71.  Kim Y-E, Lim JS, Hyung WJ, Lee SK, Choi J-Y, Noh SH, et al. Clinical implication 
of positive oral contrast computed tomography for the evaluation of postoperative 
leakage after gastrectomy for gastric cancer. J Comput Assist Tomogr. 2010 
Jul;34(4):537–42.  
72.  Sauvanet A, Baltar J, Le Mee J, Belghiti J. Diagnosis and conservative management 
of intrathoracic leakage after oesophagectomy. Br J Surg. 1998 Oct 1;85(10):1446–9.  
73.  Çakabay B, AKSEL B, ÜNAL E, BAYAR S, KOCAOĞLU H, DEMİRCİ S, et al. 
Evaluating Esophagojejunostomy Anastomosis with Methylene Blue.  
74.  DeArmond DT, Carswell A, Louden CL, Simmons JD, Bayer J, Das NA, et al. 
Diagnosis of anastomotic leak: Electrolyte detection versus barium fluoroscopy. J 
Surg Res. 2013 Jun 15;182(2):192–7.  
75.  Maish MS, DeMeester SR, Choustoulakis E, Briel JW, Hagen JA, Peters JH, et al. 
The safety and usefulness of endoscopy for evaluation of the graft and anastomosis 
early after esophagectomy and reconstruction. Surg Endosc Interv Tech. 2005 Jul 
28;19(8):1093–102.  
76.  Page RD, Asmat A, McShane J, Russell GN, Pennefather SH. Routine endoscopy to 
detect anastomotic leakage after esophagectomy. Ann Thorac Surg. 2013 
Jan;95(1):292–8.  
77.  Fujiwara H, Nakajima Y, Kawada K, Tokairin Y, Miyawaki Y, Okada T, et al. 
Endoscopic assessment 1 day after esophagectomy for predicting cervical 
esophagogastric anastomosis-relating complications. Surg Endosc. 2015 Jul 14;  
  
 
 
 
97 
78.  Holmes RS, Vaughan TL. Epidemiology and Pathogenesis of Esophageal Cancer. 
Semin Radiat Oncol. 2007 Jan;17(1):2–9.  
79.  Bruce J, Krukowski ZH, Al-Khairy G, Russell EM, Park KGM. Systematic review of 
the definition and measurement of anastomotic leak after gastrointestinal surgery. Br J 
Surg. 2001;88(9):1157–68.  
80.  Blewett CJ, Miller JD, Young JEM, Bennett WF, Urschel JD. Anastomotic leaks after 
esophagectomy for esophageal cancer: a comparison of thoracic and cervical 
anastomoses. Ann Thorac Cardiovasc Surg. 2001;7(2):75–8.  
81.  Boone J, Rinkes IB, van Leeuwen M, van Hillegersberg R. Diagnostic value of 
routine aqueous contrast swallow examination after oesophagectomy for detecting 
leakage of the cervical oesophagogastric anastomosis. ANZ J Surg. 2008 
Sep;78(9):784–90.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
98 
 
 
 
 
 
 
 
 
 
11. ANNEXURES 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
99 
ANNEXURE 1 
 
Oesophago-jejunal anastomotic leak with contrast extravasation and tracking 
into the intra-peritoneal drain. 
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ANNEXURE 2 
 
 
 
 
Aspiration of contrast with opacification of the lower left tracheo-bronchial tree. 
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ANNEXURE 3 - INFORMED CONSENT SHEET 
1. This study, in which you are being asked to participate, is being conducted to assess 
the need for a routine upper GI contrast study after an oesophageal anastomosis.  
 
2. You will be randomly allocated into two groups under the study - group A and group 
B. 
If you come under group A you will be offered an upper GI contrast study which is an 
xray investigation, on the 7
th
 day after surgery and this is the existing practice. This x-
ray test will be carried out free of cost if you wish to be part of the study. 
If you are allotted to group B you will not have a routine upper GI contrast study. 
Instead you will be monitored serially for clinical features of an anastomotic leak. On 
suspicion of a leak, your treating surgeon will do a CT scan or an upper GI contrast 
study to confirm this. The rest of the treatment will continue the same. 
 
3. We do not anticipate any adverse effects in relation to not doing a routine contrast 
study. In the event of any unforeseen event happening, further treatment will be done 
without any additional cost for the patient. 
 
4. As part of the study you will be monitored daily and your heart rate, blood pressure, 
temperature, respiratory rate, white cell counts etc. will be recorded. 
 
5. The barium contrast study involves cost, manpower, irradiation hazard, allergic 
complications and a prolonged hospital stay. The main benefit from the study extends 
to the group of patients not undergoing the barium swallow thereby reducing their 
financial burden and probably cutting short their hospital stay. If it is proven that a 
routine upper GI contrast study is not required routinely after an esophageal 
anastomosis, this will be helpful to patients undergoing such operations in future. 
 
6. The study details will be kept confidential in terms of personal information received 
from patients. Only the end results of the study will be published. The primary data 
collected will be kept in a database within General Surgery Unit 3, Christian Medical 
College, Vellore and will be accessible only to the doctors conducting the study. 
 
7. Consenting to be part of the study is purely voluntary. You can withdraw from the 
study at any given point of time and no explanation needs to be offered regarding the 
same. The further course of treatment will follow the standard protocol and in no way 
will you be penalised for it. 
 
8. You are eligible for the standard care offered to all patients in CMC, Vellore. None of 
the study patients will be deprived of the available therapies. 
 
9.  Any new information regarding the findings, if significant, will be notified to you.  
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10. The upper GI contrast study involves x-ray exposure to the foetus in case of 
pregnancy. Known pregnant ladies will not be involved in the study. 
 
11. In the event of any further queries about the study, risks and benefits at any point of 
the study, you can contact Dr. Niveditha Shama at 0416 – 2282079. 
 
Format of informed consent form for Subjects  
Informed Consent form to participate in a research study  
Study Title: 
Study Number: 
Subject’s Initials: _________ Subject’s Name: ________ 
Date of Birth / Age: _______ 
Please initial box  
(Subject) 
(i) I confirm that I have read and understood the information sheet dated _________ 
for the above study and have had the opportunity to ask questions. [ ] 
(ii) I understand that my participation in the study is voluntary and that I am 
free to withdraw at any time, without giving any reason, without my medical care or 
legal rights being affected. [ ] 
 (iii) I understand that the Sponsor of the clinical trial, others working on the 
Sponsor’s behalf, the Ethics Committee and the regulatory authorities will not need 
my permission to look at my health records both in respect of the current study and 
any further research that may be conducted in relation to it, even if I withdraw from 
the trial. I agree to this access. However, I understand that my identity will not be 
revealed in any information released to third parties or published. [ ] 
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(iv) I agree not to restrict the use of any data or results that arise from this study 
provided such a use is only for scientific purpose(s) [ ] 
(v) I agree to take part in the above study. [ ] 
 
Signature (or Thumb impression) of the Subject/Legally Acceptable Representative: 
_____________ 
Date: _____/_____/______ 
Signatory’s Name: _________________________________ 
Signature of the Investigator: ________________________ 
Date: _____/_____/______ 
Study Investigator’s Name: _________________________ 
Signature of the Witness: ___________________________ 
Date: _____/_____/_______ 
Name of the Witness: ______________________________ 
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ANNEXURE 4-INVESTIGATORS PROFORMA 
 
STUDY TO ASSESS OUTCOME AFTER ESOPHAGEAL ANASTOMOSIS IN PATIENTS 
UNDERGOING BARIUM SWALLOW STUDY VERSUS PATIENTS NOT UNDERGOING THE 
BARIUM SWALLOW STUDY. 
 
 
PATIENT’S NAME:     AGE:  SEX: 
HOSPITAL NUMBER:     D.O.B: 
ADDRESS: 
TELEPHONE:     EMAIL ID:  
DATE OF ADMISSION: 
WEIGHT IN KG: 
HEIGHT IN CM: 
BMI: 
DIAGNOSIS: 
DATE OF DIAGNOSIS: 
INITIAL INVESTIGATION LEADING TO DIAGNOSIS AND DATE: 
1. ENDOSCOPY   : 
2. BARIUM SWALLOW/MEAL  : 
3. OTHERS: (PLEASE STATE)  : 
 
COMORBIDITIES: 
1. DIABETES MELLITUS: Y/N 
2. HYPERTENSION:  Y/N 
3. CARDIAC DISEASE: Y/N 
4. RESPIRATORY DISEASE: Y/N 
5. RENAL DISEASES:  Y/N 
6. OBESITY:   Y/N 
7. OTHERS: 
 
SMOKER:   Y/N   DURATION: 
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ALCOHOLIC: Y/N   DURATION: 
 
PRE-TREATMENT STAGING IF MALIGNANT DISEASE: 
  TUMOR- T0, Tis,   T1,   T2,   T3,   T4 
  NODES- NO NODES / LOCOREGIONAL/DISTANT 
  METASTASIS – M0, M1 
CHEMO/RADIOTHERAPY: 
1. NEOADJUVANT CHEMO OR RADIOTHERAPY (PRE-OP) 
2. ADJUVANT CHEMO OR RADIOTHERAPY (POST-OP) 
3. DEFINITIVE CHEMO OR RADIOTHERAPY (WITHOUT OPERATION BUT FOR ATTEMPTED CURE) 
4. PALLIATIVE CHEMO OR RADIOTHERAPY (WITHOUT OPERATION NOT FOR ATTEMPTED 
CURE) 
 
RADIOTHERAPY: 
DATE OF COMMENCEMENT:   DATE OF COMPLETION: 
WEEKS: 
______Gy  _________FRACTIONS 
RADIOTHERAPY FIELDS: Neck/ Thorax/ Abdomen / If elsewhere please specify: 
DOSE: Low Dose / High Dose 
COMPLICATIONS: 
CHEMOTHERAPY: 
DATE OF COMMENCEMENT:   DATE OF COMPLETION: 
AGENTS USED: 5FU / CISPLATIN/ CARBOPLATIN/ OTHERS 
CYCLES: 
DOSE: LOW DOSE/HIGH DOSE 
COMPLICATIONS: 
SURGICAL WORK-UP 
ASA STATUS: 1/2/3/4/5 
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ANAESTHESIA 
DOUBLE LUMEN TUBE: Y/N 
THORACIC EPIDURAL: Y/N 
ANALGESIA:   PCA/EPIDURAL PERIOP/POSTOP/BOTH 
EXTUBATED / INTUBATED AT THE END OF THE SURGERY: 
ANY OTHER PROBLEMS (PLEASE SPECIFY): 
ANAESTHETIC EVENTS: (OLA = ONE LUNG ANAESTHESIA) 
PRE OLA: 
  HYPOXIA 
  HYPOTENSION 
  ARRHYTHMIA 
ON OLA: 
  HYPOXIA 
  HYPOTENSION 
  ARRHYTHMIA 
OLA POSSIBLE: Y/N; IF NO PLEASE SPECIFY WHY 
 
DETAILS ABOUT SURGERY: 
DATE OF RANDOMISATION: 
PATIENT RANDOMISED TO GROUP A OR GROUP B: 
**GROUP A: WILL UNDERGO THIN BARIUM SWALLOW/ GASTROGRAFFIN SWALLOW ON POST 
OPERATIVE DAY 7. 
**GROUP B: WILL NOT UNDERGO THIN BARIUM SWALLOW/ GASTROGRAFFIN SWALLOW ON 
POST OPERATIVE DAY 7. 
DATE OF SURGERY: 
SURGERY PERFORMED WITH SITE OF ANASTOMOSIS DONE: 
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1. THORACO-ABDOMINAL 
2. CERVICO ABDOMINAL 
3. CERVICO THORACO ABDOMINAL 
TYPE OF ANASTOMOSIS: 
1. HAND SEWN CONTINUOUS 
2. HAND SEWN INTERRUPTED 
3. STAPLED 
– STAPLER SIZE____ 
CHEST: OPEN / LAPAROSCOPIC/ CONVERTED 
ABDOMEN: OPEN/LAPAROSCOPIC/CONVERTED 
ANTI-REFLUX PROCEDURE:  
- NONE 
- PARTIAL 
- TOTAL 
FEEDING JEJUNOSTOMY: Y/N 
DRAINS: -CHEST: Y/N 
  - ABDOMINAL: Y/N 
DRAINAGE PROCEDURE: NONE / PYLOROPLASTY/ PYLOROMYOTOMY/ 
PYLOROMYOMECTOMY 
COMPLICATIONS/COMMENTS: 
DURATION OF SURGERY: 
ESTIMATED BLOOD LOSS IN ML: 
INTRA OP TRANSFUSION:     Y/N IF YES NUMBER OF UNITS: 
POST OPERATIVE TRANSFUSION:     Y/N   IF YES NUMBER OF UNITS: 
POST OPERATIVE PERIOD: 
DURATION OF HOSPITAL STAY: POD___ 
DURATION OF ICU STAY: POD___   
DURATION OF HDU STAY: POD___ 
VENTILATED:     Y/N  IF YES, NUMBER OF DAYS: 
INOTROPES:    Y/N  IF YES, NUMBER OF DAYS: 
RE ADMISSION TO ICU/HDU:  Y/N  IF YES, PLEASE SPECIFY REASON: 
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RE INTUBATED:                  Y/N 
ICU/HDU RE ADMISSION DETAILS: 
RE OPERATION REQUIRED:   Y/N. 
DETAILS OF REOPERATION: 
SERIAL MONITORING OF CLINICAL PARAMETERS: 
 
 POD 
1 
POD 
2 
POD 
3 
POD 
4 
POD 
5 
POD 
6 
POD 
7 
POD 
8 
POD 
9  
POD 
10 
HR           
TEMP           
RR           
PERIT. 
RXN 
          
TC           
WOUN. 
INF 
          
HR-------HEART RATE 
TEMP---TEMPERATURE 
RR-------RESPIRATORY RATE 
PERIT. RXN--- CLINICAL FEATURES SUGGESTIVE OF PERITONITIS LIKE ABDOMINAL 
TENDERNESS/GUARDING/ RIGIDITY. 
TC--- TOTAL WBC COUNT 
WOUND INF--- ANY ERYTHEMA/DISCHARGE/ POSITIVE CULTURES FROM WOUND 
ESPECIALLY IN NECK ANASTOMOSIS. 
FEATURES SUGGESTIVE OF ANASTOMOTIC LEAK (ANY 2): 
◦ tachycardia (heart rate > 100 beats per minute), 
◦ fever (body temperature > 38°C),  
◦ tachypnea (high respiratory rate), with greater than 20   breaths 
per minute 
◦ local or generalized peritoneal reaction during physical 
examination  
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◦ leukocytosis (> 12 × 103/ml) 
◦ Wound infection in case of neck anastomosis. 
** KINDLY INFORM TREATING TEAM IN CASE ANY OF THE ABOVE FEATURES ARE SEEN. 
*** IF ANY OF THE ABOVE DEVELOP THE PATIENT CAN UNDERGO ANY RADIOLOGICAL 
IMAGING TECHNIQUE AS DECIDED BY THE TREATING TEAM. 
POST OPERATIVE DAY 7: 
DATE: 
UPPER GI CONTRAST STUDY: Y/N 
IF YES, REPORT: 
ANY OTHER RADIOLOGICAL INVESTIGATION CARRIED OUT: 
DATE: 
REASON: 
REPORT: 
DAY OF STARTING ORAL LIQUIDS: POD___ 
DATE OF STARTING SEMI SOLID DIET ORALLY: POD___ 
DATE OF DISCHARGE: 
DAY OF DEATH:  
DURATION OF HOSPITAL STAY: 
IF MALIGNANT DISEASE: 
HISTOPATHOLOGY REPORT: 
TUMOR SITE: PROXIMAL THIRD / MIDDLE THIRD / DISTAL THIRD / CARDIA / 
GASTROESOPHAGEAL JUNCTION 
TUMOR TYPE: SQUAMOUS CELL CARCINOMA / ADENOCARCINOMA / MIXED / OTHER 
BARRETS’: PRESENT / ABSENT 
NODE HARVEST NUMBER: 
PROXMIAL MARGINS: INVOLVED / FREE OF TUMOR, ____MM 
DISTAL MARGINS: INVOLVED / FREE OF TUMOR, ____MM 
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TUMOR DIFFERENTIATION: WELL DIFFERNTIATED / MODERATELY DIFFERNTIATED/ 
MODERATE TO POORLY DIFFERNTIATED / POORLY DIFFERNTIATED 
BASED ON HISTOLOGY AND SURGICAL FINDINGS: 
- PROBABLE CURATIVE RESECTION 
- POSSIBLE CURATIVE RESECTION 
- PALLIATIVE RESECTION 
POST OPERATIVE TNM STAGING:  
    TUMOR- T0, Tis,   T1,   T2,   T3,   T4 
   NODES- NO NODES / LOCOREGIONAL/DISTANT 
  METASTASIS – M0, M1 
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CLAVIEN-DINDO CLASSIFICATION OF COMPLICATIONS 
COMPLICATIONS: 
 
GRADE I: FEVER CONTROLLED WITH 
ANTIPYRETICS ONLY:          Y/N 
  SEVERE PAIN CONTROLLED WITH 
ANALGESICS:    Y/N 
 WOUND INFECTION/DISCHARGE 
OPENED AT BEDSIDE:       Y/N 
 PARALYTIC ILEUS:  Y/N 
GRADE II: WOUND INFECTION/SEPSIS 
REQUIRING ANTIBIOTIC THERAPY:     
Y/N 
 CHEST INFECTION MANAGED WITH 
ANTIBIOTIC THERAPY:     Y/N 
 ABDOMINAL INFECTION MANAGED 
WITH ANTIBIOTIC THERAPY:     Y/N 
 POST OPERATIVE BLOOD 
TRANSFUSIONS:  Y/N 
 TOTAL PARENTERAL NUTRITION:   
Y/N 
 ANASTOMOTIC LEAK MANAGED WITH 
ANTIBIOTICS ONLY:    Y/N  
GRADE III: ANASTOMOTIC LEAK WITH 
ENDOSCOPIC INTERVENTION 
NEEDED: Y/N. 
 ANASTOMOTIC LEAK WITH 
RADIOLOGICAL INTERVENTION 
NEEDED: Y/N.  
 ANASTOMOTIC LEAK WITH SURGICAL 
INTERVENTION NEEDED: Y/N.  
 OTHER COMPLICATIONS REQUIRING 
ENDOSCOPIC INTERVENTION / 
RADIOLOGICAL INTERVENTION /  
SURGICAL INTERVENTION ;   Y/N: 
PLEASE SPECIFY 
GRADE IIIA  IF NOT REQUIRING GENERAL 
ANAESTHESIA 
GRADE IIIB IF REQUIRING GENERAL 
ANAESTHESIA 
GRADE IV A RESPIRATORY FAILURE ONLY: Y/N  
OR  
RENAL FAILURE ONLY:   Y/N 
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GRADE IV B RESPIRATORY FAILURE: Y/N  
 RENAL FAILURE:   Y/N 
 SEPTIC SHOCK:   Y/N 
 MULTI ORGAN DYSFUNCTION:      Y/N 
GRADE V: DEATH OF THE PATIENT 
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ANNEXURE 5- APPROVAL FROM INSTITUTIONAL REVIEW BOARD 
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ANNEXURE 6 – DATA SHEETS 
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